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Abstract 
The purpose of this pilot study was to conduct preliminary psychometric testing on 
the Hereditary Diseases and Genetic Testing (HD-GT) scale, which was designed to 
monitor the psychosocial and behavioral impact of genetic testing for hereditary 
nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome. The pilot was part of a 
larger study which is using a descriptive correlational design with longitudinal 
components to develop, validate and evaluate monitoring tools for individuals with 
genetic-based diseases. The framework for this study was the substantive theory, 
Confronting and Accepting the Challenges of Living in Families with Genetic-Linked 
Diseases (Way et al. , 2008). 
The target population was individuals at 50% risk for inheriting HNPCC who had 
participated in genetic testing and were informed oftheir carrier status. Survey 
respondents were recruited from population-based probands comprising the Provincial 
Medical Genetics Program of Newfoundland and Labrador. Study participants (N = 75) 
were similar to the target population in terms of personal and illness-related 
characteristics. Data were collected by face-to-face interviews, telephone interviews and 
self-administered surveys between February and May 2008. 
Psychometric testing of the HD-GT scale was based on the work of Ware and 
Gandek (1998). Preliminary findings are indicative of good data quality and potential 
usability of the scale under variant administrative conditions. As well, all ofthe HD-GT 
subscales met the criteria for Likert scaling assumptions and evidence very good 
reliability and validity. 
lll 
The various subscales of the HD-GT augment what has been reported in the 
literature and also provide new insights into the psychosocial and behavioral impact of 
genetic testing for individuals and families with HNPCC. Study findings suggest that the 
family history of cancer does have a significant impact on decision-making regarding 
genetic testing. There are also indications that study respondents place high value on 
having all potentially at-risk family members participate in genetic testing, but are often 
challenged trying to convince them to accept the need for testing. 
With regard to the genetic testing process, most respondents placed high value on 
being emotionally prepared for genetic testing and having appropriate information, but 
not everyone required health care provider or family/friends support. As well, despite 
experiencing some emotional difficulty while waiting for test results, not everyone 
required support prior to and during the receipt of results. Most respondents, however, do 
place high value on receiving a follow-up letter to reinforce their genetic testing results. 
Most respondents understood the importance attached to being proactive in leading 
a healthy life and participating in cancer screening. They also believed that there was an 
increased cancer presence among young people in the family. Finally, most family 
members, young and old alike, wanted information about HNPCC, and were perceived to 
understand it, but encountered some difficulties in communicating the information to 
other family members. 
Study findings indicate that the subscales appear to be sensitive enough to measure 
the wide-range of psychosocial and behavioral implications of genetic testing. However, 
due to study limitations, generalizability of the findings is cautioned until the larger study 
is complete. The findings also provide support for previous research and suggest that 
- --------- -----
lV 
more research is needed to inform the practice of genetic counseling. There is also a need 
for further research into the psychological implications of having an inconclusive test 
result. 
Finally, study findings have important implications for nursing practice. 
Competencies required for the effective delivery of genetic services need to be built into 
the scope of professional nursing practice. If nurses are to work effectively with HNPCC 
families they must have the appropriate knowledge, education and skills to recognize the 
features of HNPCC, to take thorough patient and family histories, to provide support, and 
to coordinate care for these individuals. 
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CHAPTER! 
Introduction 
Advances in DNA technology have made it possible to predict the risk status of 
individuals with an inherited predisposition for certain conditions (Reeve, Owens, & 
Winship, 2000). In the early 1990's genetic testing became available for several cancer 
types (Bleiker, Hahn, & Aaronson, 2003). Today, it is a common and integral part of 
cancer services in many countries. Health care providers are ethically responsible for 
ensuring that the information provided about genetic predisposition risks is not 
detrimental to the psychological well-being of individuals and their families. Importantly, 
the information conveyed should be well understood by the intended recipient and 
reference recommended screening and surveillance protocols (Collins et al., 2007). 
Motivational factors behind the decision to have genetic testing are complex and 
varied (Reeve et al., 2000). It seems that when treatment options are limited (such as with 
Huntington's disease), genetic testing uptake is much lower with many at-risk individuals 
not wanting to know their status. A contrasting perspective is evident for diseases, like 
colorectal cancer (CRC), which can be effectively treated when diagnosed early. Some 
jurisdictions report a genetic testing uptake of approximately 75% for CRC (Bleiker et 
al., 2003). 
Conspicuously limited in the genetics literature are research findings on how 
awareness and understanding of a confirmed familial hereditary nonpolyposis colorectal 
cancer (HNPCC) or Lynch syndrome presence influences decision-making prior to and 
following genetic testing. As well, we have limited insight into the implications of 
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participating in genetic testing for HNPCC for individuals in affected families. 
Surprisingly, research findings have documented minimal psychological and behavioral 
impacts (Claes et al., 2005; Collins et al., 2007; Heshka, Palleschi, Howley, Wilson, & 
Wells, 2008). Certain individuals may be burdened by knowing that they are at increased 
risk for a life-threatening disease, while those testing negative for the gene mutation may 
be relieved (Bleiker et al., 2003). Other individuals may be given inconclusive results 
(non-confirmed carrier or non-carrier status) and thus must live with continuing 
uncertainty about their risk status (Lindor et al. , 2006). Finally, we have limited 
understanding of how families communicate relevant information to their members about 
their potential risks (Gaff, Collins, Symes, & Halliday, 2005; Lim et al., 2004; Mesters, 
Ausems, Eichhorn, & Vasen, 2005; Peterson et al., 2003). 
Another significant gap in the genetics literature is information on the motivational 
factors responsible for behavioral change in concordance with recommended screening 
(Bleiker et al. , 2003 ; Marteau & Weinman, 2006; McAllister, 2002, 2003 ; Meiser, 2005; 
Murakami et al., 2004). Some evidence suggests that the worry and upset felt by carriers 
may deter participation in regular screening which is crucial for prevention and early 
detection (Codori, Petersen, Miglioretti, & Boyd, 2001 ; Jarvinen, Mecklin, & Sistonen, 
1995; Lerman, Marshall, Audrain, & Gomez-Caminero, 1996). 
Several authors emphasize the need for more research in the area, with some 
advocating for incorporating qualitative methods into study designs (Bleiker et al. , 2003; 
Marteau & Weinman, 2006; McAllister, 2001; Riper, 2005). Greater interest in 
qualitative approaches over the past decade has emerged in response to the increased 
recognition given to the role played by psychosocial factors in shaping health outcomes 
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(Gregory & Way, 2008). Certainly further research is needed to increase health care 
providers' and policy makers ' understandings of the impact of genetic testing on 
individuals and families, and to use this information in planning for and implementing 
appropriate services (Aktan-Collan, Meekin, & Kaariainen, 200la; Aktan-Collan, 
Haukkala, Mecklin, Uutela, & Kaarianinen, 2001 b; Bleiker et al. , 2003; Gaff et al. , 2005; 
Hamilton, Bowers, & Williams, 2005; Jarvinen et al. , 2000; Mesters et al. , 2005 ; Tiller et 
al. , 2005). 
The purpose of the current study is to provide support for what has been reported in 
the literature to date, as well as to provide new insights regarding the psychosocial and 
behavioral impact of genetic testing for HNPCC. A qualitative database was used as the 
foundation to develop an instrument for use in the pre- and post-genetic testing phases, as 
well as during the process of genetic testing. It is believed that the use of a qualitative 
database will result in an instrument that is sensitive enough to measure the full 
psychosocial and behavioral impact of HNPCC. This instrument is being tested in the 
Newfoundland and Labrador (NL) HNPCC population. 
Background and Rationale 
HNPCC is the most common form of hereditary CRC (Lynch & de la Chapelle, 
2003). It is an autosomal dominant disorder with a germline mismatch repair (MMR) 
mutation segregating within high and intermediate risk families. Although conjectured to 
be responsible for only 1% to 3% of all CRC cases world-wide, the situation in 
Newfoundland and Labrador (NL) is quite different with estimates of up to 4 7% of all 
individuals with CRC coming from families at high or intermediate risk for HNPCC 
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(Stuckless et al. , 2007). The high prevalence of genetic based cancers in the province has 
significant implications for health policy directed toward improving the overall health of 
the population. 
HNPCC and Genetic Testing 
Microsatellite instability (MSI) is the genetic basis for tumor development in 
HNPCC. Mutations occurring in microsatellites during replication are normally repaired 
by MMR proteins. When this mechanism is impaired or deficient, as with MSI, errors are 
not corrected (Kouraklis & Misiakos, 2005). 
Gerrnline mutations may occur in one of several MMR genes. The most common 
genes are MSH2, MLHl, PMSl and PMS2, with MSH2 and MLHl accounting for 60% 
and 30% ofHNPCC cases, respectively. Significantly, extracolonic carcinomas tend to 
occur more frequently in families with the MSH2 mutation (Stuckless et al. , 2007). Other 
newer and less common mutations include MSH6 which is responsible for a more 
atypical and benign form of HNPCC, and MLH3 which is present in only a small percent 
ofHNPCC-like families (Koukaklis & Misiakos, 2005). In NL, three MSH2 gene 
mutations have been identified: exon 8 deletion, exon 4-16 deletion and intron 5 splice 
mutation resulting in deletion of exon 5 in mRNA (Stuckless et al.). 
There are several cardinal features of HNPCC that geneticists use to determine the 
high or intermediate risk status of families. Some ofthe more important clinical profiles 
include: early average age of cancer onset (i.e., early to mid-40s and lower); proximal 
colon cancer involvement (70% of cases); accelerated carcinogenesis or decreased time 
line between first detection of a tiny adenoma and its progression to carcinoma (i.e., 
I 
I 
within 2 to 3 years); increased probabiliey for new colon primaries (i.e., about 25% to 
30% within 10 years of surgical resection); and greater risk for extracolonic carcinomas 
(especially the endometrium and to lesser degrees the ovary, stomach, small bowel, 
hepatobiliary tract, pancreas, upper uro-epithelial tract, and brain) (Lynch & de la 
Chapelle, 2003; Lynch, Lynch, Lynch, & Attard, 2008; Merg, Lynch, Lynch, & Howe, 
2005). 
Genetic testing for HNPCC mutations should be offered to individuals who have a 
high probability of developing CRC d related cancers based on personal and family 
histories of the disease. This is especially true for familial cancer profiles that meet the 
Amsterdam or modified Amsterdam criteria and/or Bethesda guidelines (Halbert et al., ) 
2004). The reader is referred to Appe dix A for a summary of these guidelines. 
If DNA testing reveals that a faljllily member is a HNPCC carrier, lifetime cancer 
risk rises to approximately 90%. Conversely, if a family member is not a carrier, the 
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cancer risk returns to that of the gene al population (Chung & Rustgi, 2003). Endometrial 
and ovarian cancers occur in up to 6 % and 10%, respectively, of female mutation 
carriers. Gastric and urothelial cancers also carry a lifetime risk of about 10%. Other 
cancers, like the small bowel and biliary system, occur in much smaller proportions in 
HNPCC families (Aarnio et al. , 199~; Dunlop et al. , 1997; Stuckless et al., 2007). 
The type and time of cancer onset for HNPCC carriers varies across individuals and 
families. Lynch syndrome shows incomplete penetrance (not all mutation carriers will 
develop a cancer) and variable expressivity (individuals develop different cancers at 
different ages). The relationship between genotype (gene level mutations) and phenotype 
(physical characteristics) in HNP C is not well understood, despite the identification of a 
1 6 
large number of predisposing mutations. Stuckless et al. (2007) reported that the 
cwnulative risk of developing cancer bylage 70 is 94% in carriers of the MSH2 mutation 
in the NL population. This presents significant implications for the current study which is 
focused on this population. 
Another equally important consideration is the limited diagnostic utility of current 
DNA technologies. Despite great advaAces and the concomitant benefits for families with 
Lynch syndrome-like profiles, a MM mutation is only identified in about one-half of 
these families. This may be due to thet nability of conventional technologies to detect 
alterations in suspected genes or to identify new genes that are the responsible agents 
(Lynch et al., 2008; Merg et al., 2005). The other problem is that a significant proportion 
of families presumed to be mutation egative may have hidden alternations in known 
predisposition genes (Lindor et al., 2 06; Lynch et al., 2008). Because predictive DNA 
testing is not an exact science, a sig · ficant number of families must contend with 
inconclusive results. This reality has significant implications for health care providers. 
Psychosocial and Behavioral Implications of Genetic Testing 
Previous studies have been inconsistent in their ability to predict short- and long-
term outcomes from participating ii genetic testing (McAllister, 2002). Little is known 
about how families define themselt es within the context of hereditary cancer, how they 
communicate cancer risk information, and what influences individual members' decisions 
to undergo genetic counseling anJ testing (Peterson et al., 2003). The presence of 
hereditary cancers has been found to exert variable effects on communication patterns 
within families (Gaff et al., 2005 ; Koehly et al., 2003; Mesters et al. , 2005; Peterson et 
I 
al.) and family relations (Koehly et al.). here is also some empirical support for the 
conjecture that the family context can significantly influence members' decisions 
regarding participation in genetic testing (d'Agincourt-Canning, 2005; Koehly et al. ; 
McAllister, 2002, 2003; Mesters et al.)-1 
To date, limited research has been focused on evaluating the effectiveness of 
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genetic counseling sessions in helping mdividuals make informed decisions about genetic 
testing, in preparing them for the proc ss and in helping reduce the impact of this 
I 
technology. The evidence is conflicting on the positive effect of genetic counseling 
sessions on cognitive and affective ou comes (Braithwaite, Emery, Walter, Prevost, & 
Sutton, 2004; McAllister, 2003). Me !lister proposed that the attitudes and motivation of 
individuals towards genetic testing influence the degree of engagement in the process 
and, ultimately, variations in reactions post-testing. Despite the absence of consensus on 
the type and amount of information eeded by individuals (Bleiker et al. , 2003), some 
could likely benefit from ongoing cr tact with genetic counselors (Collins et al., 2007). 
Frequent screening for CRC ' d other HNPCC-related cancers is the norm for 
individuals who are carriers of the PCC gene. Cancer surveillance, including 
colonoscopy, has to be conducted for a lifetime, which may be distressing to many 
individuals and also carries the ris of complications (Lackner & Hoefler, 2005). Prior to 
the advent of genetic testing in the 1990' s, all individuals in HNPCC families were 
recommended to be screened based on their family histories (Halbert et al. , 2004). This 
relatively new technology may lessen the burden of screening as those who test negative 
are not required to continue the v · gorous screening schedule of their carrier relatives. 
I 
The identified knowledge gaps in the literature are important for framing the 
context of genetic counseling. Furtherm0re, genetic counselors have an obligation to 
adapt sessions to the needs and preferenbes of targeted individuals (Pieterse et al. , 2005). 
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To date, there is limited evidence to suggest that genetic counseling is based on evidence-
based theoretical frameworks. The currbnt study was conducted with the intention of 
helping to close this gap. 
I 
Problem Statement 
I 
A qualitative study previously conducted by the research team as part of the larger 
study found similar and different res Its from that documented in relevant literature. It 
was apparent from the interviews that individuals living within HNPCC families 
experience a wide range of emotion 1, psychological, social and physical issues that have 
important implications for their health and quality of life. These experiences were 
collapsed into three major thematic hategories: living in families with a strong history of 
hereditary cancer; becoming aware of genetic testing and living the process; and 
struggling to adjust (with a positive/negative test result). The data from this study was 
used to generate a substantive theo y, Confronting and Accepting the Challenges of 
Living in Families with Genetic-L nked Diseases (Way et al. , 2008). 
Following generation of the ubstantive theory, the research team used the 
operational indicators comprising/the descriptors of each property defining each category 
to draft two scales - one focusing on the genetic testing process and the other on 
psychosocial and behavioral adjustment following genetic testing. The current pilot study 
was designed to conduct prelimi ary psychometric testing on one of these scales. 
--~··------------
The Hereditary Diseases and Genetic Testing (HD-GT) scale is based on the first 
two themes from the qualitative study (li ing in families with a strong history of 
hereditary cancer; and becoming aware o genetic testing and living the process). The 
current study will add to the body of liter ture that addresses the influence of a family 
history of hereditary cancer on genetic testing decision-making, engagement in genetic 
testing, understanding and acceptance ofl ancer risk and recommended preventive 
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actions, and communications about the genetic link to cancer with family members. The 
information generated by this scale has tJ e potential to significantly influence the practice 
of genetic counseling for families with HNPCC and other genetic-linked diseases. 
Purpose and Research Questions 
The overall objective of this comp~nent ofthe project was to: a) test the feasibility 
of using the scale under variant conditio s, b) validate subscale and overall scale 
structure and, c) examine scaling (rating) methods. 
This pilot study was designed to address the following research questions: 
1. Is it appropriate to administer the scale under variant conditions (i.e., telephone, 
self-administered, or face-to-face ? 
2. How well do the various subscales of the HD-GT meet the Likert scaling 
assumptions? 
3. Are the subscales reliable? 
4. Are the subscales valid? 
10 
CHAPTER2 
LiterFtture Review 
The purpose of this review of the l'terature is to examine current research on the 
factors influencing uptake of predictive testing for HNPCC and the resulting impact on 
individuals and families . This review is ramed within the context of the substantive 
theory, Confronting and Accepting the Challenges of Living in Families with Genetic-
Linked Diseases, generated by the grounded theory phase of the larger study. The 
theory's major underlying premise is that familial contexts and individual psycho-
emotional factors influence acceptance If the hereditary link to cancer, perception of risk, 
motivation to become involved in genettc testing, reaction to and understanding of test 
results, and willingness to share test res Its with others and discuss their potential risk 
(Way et al. , 2008). 
The first section of the literature review focuses on the psychological and emotional 
l 
impacts of living in families with a stro ' g history of cancer, and the reaction to and 
acceptance of a possible genetic link to lthe disease. The second section explores how 
variable levels of engagement in the ge etic testing process may impact reactions to 
being informed about one's HNPCC status, decision-making concerning recommended 
behavioral changes and willingness to penly communicate about one' s HNPCC status to 
immediate and extended family membj rs. The final section presents an overview of the 
variant processes involved in developing monitoring tools for use in clinical settings. 
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Familial Cane rand the Genetic Link 
It is estimated that close to 1000 families worldwide have the gene mutation that is 
responsible for HNPCC. Many individuals in these families have negative experiences 
related to losing relatives to cancer at a young age, caring for family members with 
I 
cancer, and worrying about cancer risk for the self as well as one' s siblings and children 
(Carlsson & Nil bert, 2007). Despite the increased identification of families with HNPCC, 
limited documentation exists on the ps chosocial and emotional burden of living with an 
uncertain or evolving disease state, and short- and long-term quality outcomes. Further, 
the available data is limited on the factlrs influencing individuals' decision to have 
genetic testing and their motivation to ollow recommended screening protocols with or 
without genetic testing. 
Family Context and Risk Perception 
Relatively few studies have examined the role played by the familial cancer context 
I 
in shaping perceptions of personal ris or implications for siblings and offspring. 
Significantly, little is known as well about how families define themselves within the 
context of hereditary cancer, how mer bers deal with personal and others' cancer 
experiences, and how individuals make the decision to undergo genetic counseling and 
testing (Mesters et al. , 2005; Peterso et al. , 2003). 
The available evidence suggest! that experiences with familial cancer and the 
resulting understandings about one' s risk influence an individual ' s decision-making prior 
to and following genetic testing for PCC (Bleiker eta!. , 2003 ; Marteau & Weinman, 
2006; McAllister, 2002, 2003; Meis r, 2005; Murakami et al., 2004). The most 
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enlightening insights into the importance of the family context for shaping risk 
perceptions, and how individuals prepare for and become involved in the process are 
provided by qualitative studies (d' Agin ourt-Canning, 2005; McAllister, 2002, 2003). 
What these two researchers have in convnon is the priority given to experiences with 
close and distant relatives and the perso al interpretations of these experiences in shaping 
perceptions of risk. 
In a qualitative study of women' s experiences with genetic testing for hereditary 
breast and ovarian cancer, d' Agincourt-Canning (2005) explored the connection between 
experiential knowledge gained from li ing with a family history of these diseases and 
personal understandings of cancer risk. Thematic analysis yielded two major categories 
of experiential knowing - empathetic (cancer knowledge constructed from family 
communications about the high preval nee, or exposure to disease progression and 
treatment responses in others, or car in~ for affected others) and embodied (personal 
physical and emotional experiences w'th cancer and its treatment). Both of these ways of 
knowing are purported to be used in c nstructing theories of cancer risk for the self and 
others (sense of vulnerability and/or pr ceived threat). This author concludes that the 
strong impact of personal experiences of cancer within the self or with others on 
perceptions of risk highlights its importance as a focus for genetic counselors to help 
better prepare individuals for genetic esting. 
McAllister (2002, 2003) used a rounded theory approach to generate a Theory of 
Engagement which proposes that variable levels of cognitive and emotional involvement 
I 
in the family cancer context are key factors influencing conceptualizations of risk about 
HNPCC and, ultimately, intensity of engagement in the genetic testing process. It is also 
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conjectured that the engagement process is a psychosocial one influenced by discussions 
about the familial cancer history, personal theories of inheritance (lay theories), coping 
styles and social factors (i.e., degree of ersonal experience with cancer in the self or 
other family members). The theory also proposes that the engagement process 
continuously evolves along a continuum from disengagement through partial (cognitive 
. 1) . ( . . ld . 1 . ) processmg on y to mtense cogmtlve an emotwna processmg engagement. 
Genetic Testing Decision-Making 
Individuals in HNPCC families seek genetic counseling for a number of reasons. 
Families play a key role in influencing individual members' awareness of cancer risk and 
decisions about genetic testing (Bleiker et al. , 2003). Common motives for accessing 
genetic counseling services include a desire to obtain information about genetic testing, to 
discuss the family history, to get infor~ation on early detection and prevention, to obtain 
emotional support, and/or to reduce wbrry (Pieterse et al. , 2005). Additional motivating 
factors include wanting to avoid unnecessary screening, to clarify one's status for the 
benefit of offspring and/or to inform reproductive decisions (Bleiker et al.; Carlsson & 
Nilbert, 2007; Claes et al., 2005; Me llister, 2002). 
Research studies have been designed to quantify the impact of psychosocial and 
personal characteristics on genetic te ting uptake. Study findings suggest that there tends 
to be a greater likelihood of genetic testing uptake in HNPCC families in the presence of 
personal experiences with cancer and/or exposure to a large number of affected relatives 
(Hadley eta!., 2003) and greater perceived cancer risk or more frequent thoughts about 
cancer (Codori et al. , 1999). Other r searchers have found support for the positive impact 
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of an absence of depressive symptoms ( erman et al., 1999), higher education (Lerman et 
al.) and active employment (Aktan-Collan et al., 2000) on genetic testing uptake. 
Following a critical review of literature on psychosocial issues in cancer genetics, 
Bleiker et al. (2003) reported that perce-'ved risks for cancer, more so than objective risks, 
are important influencers of genetic testing uptake. What this means is that if perceived 
susceptibility is high, individuals may sl ek genetic testing to decrease uncertainty, to 
confirm/refute the need to engage in preventive actions, to determine risk for children or 
to engage in future/family planning. These authors also noted that the research findings 
suggest that individuals seeking geneti testing tend to overestimate their risk and do not 
recall risk information very well. Furt ermore, standardized education and counseling 
programs appear to have limited impa t on modifying subjective risk perceptions. 
Finally, the evidence also suggests tha high levels of distress and poor coping styles may 
· d h · f · k · c. I. tmpe e t e processmg o ns tn1orma ·ton. 
Studies conducted after Bleiker et al. 's (2003) review reinforce some of these 
findings. In a cross-sectional survey o1 130 individuals attending a cancer clinic, 
Balmana, Stoffel, Emmons, Garber, d Syngal (2004) used a researcher-developed 
instrument to investigate the motivations and concerns of individuals prior to genetic 
counseling and testing for different h€reditary cancer syndromes. Significant among the 
I 
study findings was that most participants entered the process expecting a positive test 
result for the targeted syndrome and believed that they were at high to very high risk for 
cancer. As well, genetic testing see ed to be an enabling force behind decision-making 
about cancer prevention and medica management. Further, respondents believed that 
genetic testing would influence their future planning and their children's lives. 
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In a prospective study of 121 individuals with a family histmy of breast and colon 
cancer, Carlsson, Bjorvatn, Engebretsen Berglund, and Natvig (2004) used standardized 
scales to assess cancer distress levels, self-efficacy, perceived social support and health-
related quality of life. The findings in t e pre-genetic counseling period indicated that 
one-fifth of the sample had significant ~stress scores. As well, less cancer-related 
distress and greater self-efficacy and pe ceived social support were found to be 
significantly associated with better mental health. 
Summary 
Currently, there is limited insight into the role played by the family context in 
shaping individuals' perceptions ofJPCC, including how they define their risk, make 
decisions about genetic counseling an testing, and communicate relevant 
information/experiences to other pote tially at-risk family members. It has been 
conjectured that personal interpretatio s of experiences with familial cancer may shape 
perceptions of risk and influence engagement in the genetic testing process. With the 
available evidence suggesting that per eived cancer risk has a greater impact on genetic 
testing uptake than objective risk, genr tic counselors should focus on developing greater 
insight into personal theories of risk. n short, more research is needed to understand the 
importance of the familial cancer con ext for shaping risk perception and genetic testing 
decision-making. 
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Genetic/ Testing Process 
Collins et al. (2007) maintains tha it is an ethical requirement of counseling 
programs for genetic testing to ensure t at the information provided is understood by 
patients. The review of literature for the current study found few investigations that 
focused on evaluating how effective genetic counseling sessions are in preparing 
individuals for or reducing the impact o genetic testing. There also seems to be limited 
consensus on optimal counseling programs for ensuring that individuals make informed 
decisions and experience minimal negative impacts from this new technology. 
Some authors argue that there is o evidence to support the premise that genetic 
counseling sessions increase the know edge base and understanding levels of individuals 
(McAllister, 2003). However, in a syst matic review and meta-analysis of the genetic-
based literature, Braithwaite et al. (2004) did find support for increased knowledge of 
cancer genetics following genetic co seling. 
Involvement in the Process 
McAllister (2002, 2003) propos d that the psychological concept of engagement 
influences attitudes and motivation t ards genetic testing for HNPCC. McAllister 
(2003) conjectured that variations in degrees of engagement may help explain differences 
in how individuals approach and reaot to genetic testing. Engagement can be partial 
(cognitively aware of the 50:50 inhe /itance probability) or intense (fearful and anxious 
with strong convictions about one's carrier status), with disengagement occurring if the 
I 
whole idea about the inheritability of cancer is unacceptable or too painful. 
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The research evidence suggests th t many individuals with a family history of CRC 
experience high levels of perceived risk for developing the disease (Bleiker et al. , 2003 ; 
Braithwaite et al., 2004; Croyle & Lerman, 1999). Elevated risk perceptions for cancer 
have been associated with psychologic~ distress prior to, during and following genetic 
testing (Bleiker et al.; Esplen et al. , 2003). 
In an updated review of the litelature, Meiser (2005) explored the psychological 
and behavioral impact of participating n the genetic testing process. One important 
finding not referenced previously was he limited information available on how the 
delays experienced by certain individJals while waiting for their test results could 
enhance psychological distress. The author highlights this as a significant gap because of 
the probability of increased frustratioJ and distress when future decision-making about 
. d hi . . . / . . h 1 screenmg an prop y actic mterventl ns 1s contmgent upon sue resu ts. 
Bleiker et al.'s (2003) review[; 'led to detect evidence-based data on the 
professional service needs of individuals and families undergoing predictive genetic 
testing. These authors argued that mdre research is needed to determine the type and 
amount of information required pre- and post-testing, how to provide better 
understanding of genetic testing and its effects, and how to best facilitate risk-reducing 
behavior without increasing emotio al distress or providing false reassurances. 
Individuals who should be targeted for greater guidance and support are "family 
messengers." Other individuals who may require greater attention include those who fall 
l 
into the following categories: expo ed to cancer in a family member at a young age and 
thus could be at greater risk for ad erse emotional consequences; experienced high levels 
of distress prior to testing; experienced the loss of a close relative to cancer shortly before 
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. 1 . "h I fu d . . . I d testmg; persona expenence wit cancer· re se to receive genetic testmg resu ts; an , 
experienced a discrepancy between exp cted and actual outcomes of genetic testing. 
Pieterse et al. (2005) noted that the evidence suggests that it is important to identify 
the needs and concerns of individuals s eking genetic counseling in order to better 
support them, lessen their anxiety and discuss complex issues with them. These authors 
developed an instrument to measure th needs and preferences of individuals 
participating in genetic counseling for ereditary cancer. Study findings suggest that a 
major concern of individuals prior to counseling is wanting information about personal 
and family members risk, preventive s rategies, and the genetic testing process. 
Reaction to HNPCC Status 
The consequences of genetic testing vary widely depending on the individual and 
family. Certain individuals may beco e burdened by knowing that they are at increased 
risk for developing a life-threatening isease (Bleiker et al., 2003). Other individuals may 
experience anxiety and worry, feel guilty about passing on the gene and experience 
uncertainty about future health states (Claes et al., 2005; Esplen et al., 2003). Besides the 
psychological and emotional repercussions, there may be negative effects on family 
relationships, a loss of privacy and discrimination by insurance companies and employers 
(Bleiker et al.; Carlsson & Nilbert, 007; Hadley et al., 2003). 
Although a negative genetic test result should provide relief, the literature describes 
what is known as 'survivor's guilt' L ong persons not found to have the gene mutation 
for HNPCC (Bleiker et al. , 2003). In addition, while the risk for non-carriers ofHNPCC 
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is the same as that of the general population, these individuals may find it difficult to 
discontinue screening (Hadley et al. , 2094). 
Based on an extensive review of relevant literature, Bleiker et al. (2003) reported 
that the general conclusion of research studies and meta-analyses is that there are no 
adverse psychological consequences fr<;>m engaging in predictive testing. These findings 
have been attributed, in part, to the imBact of genetic counseling on reducing anxiety and 
improving accurate perceptions of risk However, Bleiker et al. argue that the assertion 
that genetic counseling decreases psychological distress and increases knowledge/ 
perception of risk is mostly based on s eculation. 
Braithwaite et al. (2004) conduced a systematic review and meta-analysis of 
controlled trials and prospective studies focusing on outcomes of genetic counseling for 
familial cancer. The analysis reveale conflicting findings for cognitive and affective 
outcomes. Genetic counseling was o 1served to exert a consistent positive effect on 
knowledge of cancer genetics in both controlled trials and prospective studies. In 
contrast, no significant effects were bserved for either risk perceptions or risk accuracy 
in the controlled trials, but significi t improvements in risk accuracy were reported for 
most prospective studies. Similarly, the controlled trials, for the most part, failed to 
document a significant effect for genetic counseling on levels of general anxiety, general 
distress, depression or cancer-specific worry. In contrast, prospective studies documented 
statistically significant reductions in general anxiety in the short-term, inconsistent 
findings concerning reductions in eneral distress, no significant impact on depression 
and significant short but not long-term reductions in cancer-specific worry. 
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Meiser (2005) reviewed the literature on the psychological impact of genetic testing 
for hereditary breast/ovarian cancer sus eptibility, HNPCC and Familial Adenomatous 
Polyposis (F AP). This author found that HNPCC studies consistently reported that 
unaffected non-carriers experience benefits (short- and long-term decrease in colon 
cancer anxiety, generalized anxiety, and depression) and evidence no adverse long-term 
effects from having genetic testing. Wi h regard to carriers, there were only temporary 
I 
increases in generalized anxiety immeqiately following disclosure of test results. It was 
common to also see short- and medium-term decreases in depression. Meiser concluded 
I 
that these results may reflect the demonstrated effectiveness of screening for HNPCC. 
l 
A final important point emerging from Meiser' s (2005) review is that it is not 
always possible to identify the specifi gene mutation from tumors taken from family 
members with cancer. In fact, gene mutations are only identified in 50% of families with 
aggregate cancers, thus leaving a fair ly large number of individuals with inconclusive 
results. The challenges here are two- old. First, the absence of a known gene mutation 
may create false assurances regarding cancer risks. Second, certain individuals may 
experience psycho-emotional difficulties with the uncertainty of inconclusive results. 
I 
Several studies have been conducted since these literature reviews of earlier studies. 
Prospective studies have collected b seline and follow-up data on individuals 
participating in genetic testing. The e studies are increasing our understanding of the 
psychosocial, medical, and behavioral impact of testing for mutations that predispose to 
cancer (Claes et al., 2005; Collins et al., 2007; Esplen et al. , 2007). 
Claes et al. (2005) assessed d stress (cancer-specific, state anxiety, global 
dysfunctioning) and illness representations (risk perception, perceived severity, and 
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perceived controllability of disease) in a sample of carriers and non-carriers of HNPCC 
one year after disclosure of genetic test results. A second focus of the study was to 
identify the best predictors of lower dis ress levels. Study results confirmed previous 
findings that genetic testing for HNPCC does not induce major psychological problems. 
The authors speculated that this may be attributed to focusing on the benefits of regular 
screening for early detection of cancer.! 
A more recent study on the psychological impact of HNPCC testing found that 
cancer worry, anxiety and depression levels either increase or remain the same for 
healthy carriers immediately after notification of test results compared to non-carriers 
(Esplen et al. , 2007). As well, despite the tendency for increased distress levels to return 
to baseline at one year post-disclosur of genetic testing results, there continues to be a 
significant group of individuals who ave elevated psychological symptoms, especially 
young female survivors, non-whites, the less educated and those with less social support. 
Other factors that affect distress include coping style and experience with loss. 
Collins et al. (2007) also studied the impact of genetic testing three years after the 
receipt of results for predictive testipg for HNPCC (N = 114). The findings suggested that 
the carriers' distress levels at 3-ye s were similar to those observed at 12-months (N = 
73). As well, depression levels were very low and had returned to baseline. 
Heshka et a!. (2008) conducted a systematic review of existing studies dealing with 
perceived risks and the psychological and behavioral impacts of participating in 
predictive DNA testing for variou cancers, including HNPCC. The authors found that 
overall, genetic testing had no significant impact on psychological outcomes (general and 
specific distress, anxiety, or depression) in either carriers or non-carriers. The impact on 
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cancer worry was less conclusive due to the limited comparative research. In addition, no 
significant differences were observed in the risk perceptions of carriers and non-carriers 
at 12 months which was lower than at baseline in most studies. The authors concluded 
that genetic testing does not appear to have negative repercussions for carriers or non-
earners. I 
Decision-Making and Behavioral Ch nge 
One important potential benefit f genetic testing for HNPCC is being able to make 
informed decisions about cancer screening directed toward helping reduce the incidence 
of and mortality from CRC (Collins Jt al., 2007; Hadley et al. , 2003 ; Reeve et al., 2000). 
However, it cannot be assumed that arriers will necessarily adopt appropriate screening 
and preventive behaviors following genetic testing (Meiser, 2005). It is argued that 
quantitative studies have not been c nsistent in their ability to predict outcomes from 
genetic testing (McAllister, 2002). he extent to which a condition is considered to be 
preventable is an important predicto of whether or not individuals engage in screening 
(Marleau & Croyle, 1998). I 
In a systematic review and meta-analysis of studies focusing on genetic testing for 
cancer, Braithwaite et al. (2004) odly identified a few studies that addressed cancer 
surveillance practices, with most documenting minimal changes in behavior. According 
to Meiser (2005), the focus of exis ing literature has been largely on the psychological 
impact of genetic testing, thus more research is needed on the behavioral impact of this 
technology. In a systematic reviej of studies dealing with the behavioral impact of 
participating in predictive DNA testing, Heshka et al. (2008) found that, for the most part, 
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self-reported screening practices (e.g., mammography, transvaginal ultrasound, cancer 
antigen, colonoscopy, etc.) increased post-genetic testing for both groups but significantly 
more so for carriers. I 
In their follow-up study, Claes et al. (2005) also assessed the health-related 
behavior ( colonoscopy and transvaginal ultrasound) of carriers and non-carriers of 
HNPCC one year post-genetic testing.~e hypothesized higher subjective risk 
perceptions of carriers versus non-ca~ers were not confirmed, but carriers did have 
higher uptake of screening post-testing. 
Bleiker et al. (2005) conducted t study of 149 individuals who had undergone 
genetic counseling for CRC and advised to undergo periodic screening because of 
familial CRC or HNPCC. Participants were invited to complete a self-report 
questionnaire on psychosocial issues and screening practices. Noncompliance with 
screening advice was rare (3%) but ignificant delays (more than 1 year) were reported 
by approximately 25% of responde ts. Some of the identified barriers to screening 
included not receiving a reminder letter, the embarrassing nature and discomfort 
associated with the procedure, fear hat a tumor would be detected, and absence of 
symptoms. 
Collins et al. (2007) also inv stigated the screening practices of carriers and non-
carriers three years afte~ predictive testing for HNPCC. All confirmed carriers had a 
colonoscopy within three years. The finding that only 7% of non-carriers had a 
colonoscopy suggests that these individuals are reassured by a negative test result and are 
willing to discontinue screening. ~oteworthy is that these findings contrast with those of 
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other studies which suggest that non-e iers might be reluctant to discontinue screening 
(Hadley et al., 2004). 
Some research studies have focus don identifying possible factors responsible for 
screening uptake. The evidence from these studies suggests that distress levels (intrusive 
I 
thoughts about cancer, grief, anxiety and depression) may negatively impact how willing 
an individual is to follow screening prJtocols which are crucial for prevention and early 
detection (Codori et al., 2001; Jarvine et al. , 2000; Lerman et al. , 1996). As well, there is 
some support for the fact that individuals with greater social supports and who live in 
families with open communication patterns are more likely to participate in regular 
screening (Johnson, Trimbath, Peters n, Griffin, & Giardiello, 2002; Keller et al., 2002). 
Physicians and other primary health care providers also play a critical role in 
helping individuals follow recommended surveillance and screening protocols (Esplen et 
al. , 2007; Hadley et al. , 2004; Lindor et al. , 2006; Stermer, Hodgson, Kavalier, Watts, & 
Jones, 2004). Clinicians should bee/ me actively involved in providing follow-up care to 
individuals after confirmation of ~PCC in the family. An important function is 
encouraging individuals to engage i, recommended screening protocols (Lindor et al. ; 
Lynch et al. , 2008; Merg et al. , 200:5). Hadley et al. (2008) reported that HNPCC carriers 
screened more frequently when the share genetic testing results with family physicians. 
Communication about HNPCC Risk 
Hereditary cancers may affett family communication patterns as well as 
relationships among members. In many families, the affected person typically 
communicates information about hereditary cancers to other members. How accurate this 
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information is and how it is communica 'ed have implications for how other family 
members understand their risk, become involved in genetic counseling and testing and 
decide to engage in screening (Gaff et I., 2005; Koehly et al., 2003; Peterson et al. , 
2003). 
The literature suggests that individuals in HNPCC families may struggle with the 
responsibility of conferring information about a hereditary predisposition to cancer to 
other family members (Carlsson & Nilbert, 2007; Esplen et al., 2007). Many individuals 
I 
also experience concerns for family members, children or potential children (Bleiker et 
al., 2003; Carlsson & Nilbert; Claes tal. , 2005; Esplen et al.; Hadley et al. , 2003). In 
I 
arguing for more qualitative inquiries, McAllister (2002) noted that case studies and 
interview studies have identified co plex family issues (i.e., pre-selection, scapegoating, 
survivor guilt, family communicati n difficulties and worry about children's risk) which 
I 
may be difficult to detect with standardized questionnaires. 
In a qualitative study Peterson et al. (2003) explored the psychosocial impact of 
predictive testing for HNPCC within the family context. These authors argued that the 
research base is limited on how farilies communicate information about genetic 
counseling and testing for HNPCC. The article describes how information is dispersed, 
when and under what circumstan~es information is shared, and how family members 
react to and act on the informati n received. Study findings indicated that communication 
about risk for HNPCC differed t om that reported for other genetic diseases, like 
Huntington's disease. It was conjectured that cancer survivors are more willing to engage 
in open discussions and particii?ate in such beneficial behaviors as counseling and testing. 
However, the authors noted that simply communicating information about risk potential 
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may not be enough and that follow-up an6 encouragement might be needed. In addition, 
family members with hereditary cancer who have contact with geneticists and genetic 
counselors may need to become intermediaries for at-risk relatives. As well, these 
individuals may need help with their adv I cacy role from spouses and unaffected family 
members. The authors also suggest that family members who become messengers may 
benefit from professional guidance. 
Koehly et al. (2003) reported on thj relational aspect of hereditary cancers from a 
psychosocial perspective. A study was designed to examine the broader family context 
and family systems in order to gain betteJ insight into how these components influence 
family members' actions. The findings i[\dicated a general tendency for individuals with a 
confirmed hereditary predisposition for cancer to discuss their experiences with genetic 
testing and counseling. As well, these coE unications tended to occur more frequently 
with first-degree relatives, close friends, . d spouses. Finally, individuals from families 
with positive functional relationships (co esion, positive leadership, communication, and 
active involvement) were more likely to engage in discussion about genetic counseling 
and genetic testing than those from families with lesser amounts of these characteristics. 
Mesters et al. (2005) reported on th findings from a qualitative study that 
investigated individuals' experiences (reasons for, the process and extent of disclosure) 
with informing family members about ~PCC. Study findings suggested that individuals 
disclose information because of moral obligatory feelings and anticipated regret from not 
doing so, encouragement from medical care providers and/or significant others, and 
personal and family history of cancer ( es ecially deaths of relatives). Participants 
discussed the hereditary information wit in the nuclear family only (first degree relatives 
27 
and spouses). The level of disclosure by tudy participants was limited to informing 
others about the condition's presence an the availability of genetic testing. More detailed 
information was left to the experts. Interestingly, the authors found that if the messenger 
encountered many negative responses, hJ or she was less likely to be willing to continue 
the disclosure process. However, it was so noted that if health care professionals 
stressed the importance of disclosure, this motivated the messengers. 
Gaff et a!. (2005) presented a brief overview of previous study findings on 
I 
individuals' experiences with disclosure of information to family members. The authors 
noted that closeness of the family member genetically and socially, perceived relevancy 
for a family member, perceived potential for harm, age of the family member (children 
more likely to be informed), and gender fthe informant (women more so than men) 
influence disclosure patterns. Other factors that may affect disclosure include beliefs 
about the importance of knowing and the right to know, as well as prior experience with 
others' reactions to distressful information. 
The study by Gaff et a!. (2005) was designed to assess the usefulness of a 
counseling session and information booklet in helping family members with hereditary 
cancer engage in full disclosure to all potentially at-risk relatives. Study findings 
indicated that male participants had a gre ter need for professional support than did 
females. In addition, despite not feeling the need for communication aids, participants 
supported having a letter summarizing the consultation results and an HNPCC 
information booklet to ensure that relatives received accurate information. Interestingly, 
although willing to disclose information l bout genetic testing, study participants did not 
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tell all at-risk family members. The authors noted that it did not seem to be a deliberate 
decision not to tell, but rather a result of poor communication pathways. 
It is argued by some authors that individuals could benefit from ongoing contact 
with geneticists in order to receive up-to-date information about HNPCC and its 
management as well as support with disclosure to other family members (Collins et al. , 
2007; Gaff et al. , 2005; Koehly et al. , 20@3; Mesters et al. , 2005; Peterson et al., 2003). 
Given the wide range of potential implications for an individual who undergoes genetic 
testing for HNPCC, several authors advobate for a multidisciplinary counseling context in 
which to offer this service (Claes et al. , 2005; Collins et al.; Meiser, 2005). 
It is also recommended in the literature that genetic counselors should attempt to 
identify existing communication patterns within families and suggest ways that family 
members can take an active role in encouraging others to learn about their cancer risk and 
options for testing (Gaff et al., 2005; Ko hly et al., 2003; Peterson et al., 2003). As 
genetic testing and counseling programs become more widely available, it is important to 
assess the psychological and social impact that this information has on individuals and 
families in order to provide the best profl ssional support possible (Bleiker et al., 2003). 
Crucial in the process as well, is the autonomy of the individual and their ability to make 
informed decisions regarding testing and screening. Counselors must assess the needs and 
preferences ofthose they are counseling and adapt their sessions accordingly (Pieterse et 
al., 2005). 
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Summary 
Research is needed to facilitate the development of sound theoretical models and 
provide the basis for appropriate genetic counseling. Otherwise, the provision of genetic 
testing may be ill-informed, ineffective, l nd counter-productive (Meiser, 2005). Future 
research should focus on ways to broade I the concept of the nuclear family in order to 
provide consistency in communication ~d disclosure, how written information provided 
by experts is being used, and helpful approaches or informant need for support. HNPCC-
affected individuals and their relatives may benefit from specific guidance and advice on 
how to ensure that all those who are at ri k receive the information they need, and that 
they understand the importance of receiving education and counseling to help manage 
their hereditary cancer risk (Peterson et ., 2003). 
Instrument Development 
Although genetic counseling strategies may be evidence-based, we know very little 
about what actually happens in counselirW sessions especially in terms of their impact on 
individuals and families (Bleiker et al. , 2003 ; Carlsson & Nilbert, 2007; Hadley et al. , 
2003; McAllister, 2001). The argument J ut forth by certain authors is that the existing 
research base on genetic testing decision1making is primarily descriptive and in need of 
theoretical models to guide inquiries into this area (Braithwaite et al., 2004; Etchegary, 
2004; Gooding, Organista, Burack, & Bi seeker, 2006; McAllister, 2001; Shiloh, 2006). 
One group of researchers/theorists support the use of existing theory, especially 
social cognition models (Etchegary, 200 ), Self-Regulatory Theory (Shiloh, 2006) and 
stress and coping models (Gooding et al. 2006). The position taken is that these models 
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will facilitate insight into the predictive ~ower of key influencing and mediating factors 
in genetic testing uptake and quality cognitive, affective and behavioral outcomes post-
genetic testing. In contrast, other author identified the need for more theoretical and 
empirical research into factors influenci g quality genetic testing decision-making and 
outcomes in the short- and long-term fol owing confirmation of familial HNPCC (Bleiker 
et al. , 2003; Marteau & Weinman, 2006; McAllister, 2001; Riper, 2005). 
In addition, studies which have use standardized instruments for assessing 
psychological states (depression, impact of event, anxiety, worry and concerns) have not 
been consistent in their ability to predict !Psychosocial and behavioral outcomes from 
genetic testing (McAllister, 2002). In fact, the limited support for differences in distress 
levels between carriers and non-carriers IDf inherited diseases has been used to inform the 
practice of genetic counseling (McAllister, 2001 ). It is, therefore, important both 
theoretically and clinically to develop social psychological models that have greater 
explanatory power to inform the content of and the approaches used to deliver genetic 
services (McAllister, 2002). 
According to Gregory and Way (2 08) it is important to focus on the total illness 
experience - behavioral, social, psycho I gical, and emotional - if we are to truly 
understand what it means to live with a chronic illness. In fact, greater interest in 
qualitative methods has emerged over th . past decade in response to the increased 
recognition that is given to the role of ps chosocial factors in shaping health outcomes 
(Gregory & Way). It is argued that the insights gleaned from qualitative data can be used 
to help researchers design instruments w ich are more sensitive to participants' meanings 
and interpretations (Coyle & Williams, 2 00; Gregory & Way; McAllister, 2001 ). Gilgun 
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(2004) contends that solid qualitative research provides confidence in the content and 
face validity of clinical tools, and produces clinical tools that have excellent psychometric 
properties. 
Based on the current review of lite ature, two researcher-developed instruments 
were identified that assessed motivation or genetic testing, as well as the concerns, needs 
and preferences of those seeking testing. Balmana et al. (2004) noted the presence of very 
few instruments which could be used to assess motivation and concerns related to genetic 
testing in hereditary cancer syndromes. These authors created an instrument based on 
their clinical experiences. Pieterse et al. ~2005) also developed an instrument to measure 
needs and preferences in genetic counsel· ng for hereditary cancer. This instrument, unlike 
the one by Balmana et al., was developed from the perspective of those seeking 
counseling. 
Substantive Theory 
Grounded theory methodology is useful for capturing basic psychosocial processes 
that form a substantive theory. The main Lbjective of grounded theory is to facilitate a 
better understanding of human behavior d interactions within differing and similar 
contexts. The inductive - deductive appr~ach is focused on generating theory as opposed 
to testing it (Gregory & Way, 2008; McAllister, 2001). 
The framework used for the curren, study is presented in Figure 1. The figure 
depicts the substantive theory, Confronti g and Accepting the Challenges of Living in 
Families with Genetic-Linked Diseases. ~tis based on the findings from a qualitative 
study conducted as part of the crCIHRt interdisciplinary project (Way et al. , 2008). 
Figure 1 Confronting and Accepting the Challenges of Living in 
Fami lies with Genetic-Linked Diseases 
Living in Families 
with a Strong 
History of Cancer 
I 
'+Ill-== -- Acceptingr----
the Challenge 
Becoming Aware 
of Genetic Testing 
& Living the 
Process 
\ 
~---W.-truggling to 
Adjust (with a 
positive/negative 
test result) 
Quality 
Outcome 
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The theory is comprised of three major constructs derived from the lived experiences of 
carriers and non-carriers ofHNPCC: 1) iving in families with a strong history of cancer, 
2) becoming aware of genetic testing and living the process and, 3) struggling to adjust. 
The substantive theory infers that the individual's family history and experience 
with cancer are important factors influe9cing how well individuals accept the hereditary 
link to cancer and are motivated to becor e involved in genetic testing. It is argued that 
this context is an important entry point arker because it influences the individual's 
cognitive thought processes in his or her search for meaning and understanding and, 
ultimately, impacts integration of the faoL on emotional and behavioral levels. 
The major underlying premise of the theory is that the first two constructs exert 
separate and interactive effects on each other and the third construct, struggling to adjust. 
All of the constructs are linked by the unifying thread of accepting the challenge. 
Psychosocial and behavioral adjustments waver in response to new challenges (e.g., 
adversities of screening protocols, progr ssion to affected states, the suffering and early 
deaths of affected relatives). Adjustmen is also influenced by ease of access to a 
supportive health care system (meaningful information, timely screening and treatment 
opportunities, psychosocial supports) and family/friendship networks. At the final step, it 
is inferred that living in families with a strong history of cancer and becoming aware of 
genetic testing and living the process exert a direct effect and indirect effect through 
struggling to adjust on quality outcome. swell, struggling to adjust exerts a direct effect 
on quality outcome. 
The first construct, living in families with a strong history of cancer, gives a starting 
point for developing an appreciation of the intensity of the individuals' struggles with 
multiple losses and how this shapes their search for meaning and understanding. It is 
comprised of two properties: 1) struggling with multiple losses - conflicting emotions 
and, 2) searching for meaning/underst !ding/certainty. These properties attempt to' 
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describe the experience of living with tHe presence of cancer in the family and the effect 
this has on family members. When indi iduals have struggled with the family cancer 
experiences, they have a sense of loss resulting from the worry and concern that goes far 
beyond the illness itself. The experienc s of cancer in the family also influence the 
perception of risk for individuals. j 
The second construct, becoming a I are of genetic testing and living the process, is a 
continuation of the genetic testing proc ss to its end point - confirmed carrier or non-
carrier status. It is comprised of four pr perties: 1) moving closer to puzzle completion, 
2) meaning of genetic testing, 3) penetr ce - dispelling beliefs and developing greater 
awareness, and 4) communicating with thers - openness versus concealment. 
Following contact with the geneticist, family members meaning base was expanded 
to include the increased probability of a hereditary component to the cancers. Although 
this provided them with greater certaintr concerning the causal factor behind the cancers, 
uncertainty was also increased as they confronted a greater potential cancer risk for 
themselves and their families. The second property (meaning of genetic testing) focuses 
on how participants perceived the various ways in which they received their results, how 
they reacted to being informed about thL r carrier status, how well they understood their 
risk and how well they incorporated this into actionable knowledge in terms of screening. 
The third property deals with the processing of the information received regarding carrier 
status on both a cognitive and an emoti nallevel. Existing beliefs about inheritance 
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contributed to acceptance or non-accept ce of these facts. The final property deals with 
how open individuals were about disclosing the results of genetic testing within and 
outside the family. There appears to be I uch variability regarding the ease of discussing 
this topic and the issue of who to tell and not to tell. 
In this study, the research team used data from the first two constructs in the 
substantive theory to draft a scale. Living in families with a strong history of hereditary 
cancer, and becoming aware of genetic esting and living the process, were utilized in the 
development of the HD-GT scale. A more detailed description of the steps involved in the 
development and testing of this instrumbnt are presented in Chapter 3. 
Discussion of Literature 
The literature reviewed for the current study highlighted the complex nature of what 
it means to live in a family with a knok gene mutation for HNPCC and the many 
potential consequences that may emanate from this diagnosis. Based on this review, it is 
noteworthy that relatively few studies ave examined the role that the family context 
plays in shaping perceptions of risk for self or others. In terms of interpreting personal 
risk and making decisions about obtaining genetic testing, research findings suggest that 
perceived risk for cancer may have mo e of an impact on genetic testing uptake than 
objective risk. 
The research evidence suggests thr many individuals with a family history of CRC 
experience high levels of perceived risk for developing the disease. This is associated 
with psychological distress prior to, d ing and following genetic testing. In addition, 
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delays experienced by some individuals while waiting for test results may enhance 
distress. 
Study findings suggest that there m y be a greater likelihood of genetic testing 
uptake in HNPCC families when there are personal experiences with cancer, a large 
number of affected relatives, and greater perceived risk for cancer. It is also conjectured 
that psychological engagement with the genetic testing process is believed to influence 
attitudes and motivation towards genetJ testing for HNPCC. It has been conjectured that 
I 
variations in the degree of psychologic engagement with the genetic testing process 
may help explain differences in how inqividuals approach predictive DNA testing and 
react to their results. 
The research evidence indicates th t there are no adverse psychological effects on 
individuals as a result of engaging in pr dictive genetic testing. These findings have 
sometimes been attributed to the positi e impact of genetic counseling. However, 
controversy exists about the definitiven ss of this causal link. One confounding variable 
is the interactive effects of personal characteristics and genetic counseling information 
sessions on psychological outcomes. 0 /her known confounders are age, gender, race, 
educational level, and the type and freq ency of informal/formal social supports. 
To date, the psychological impact f genetic testing has been more of a research 
focus than the behavioral impact. While the evidence is conclusive that regular screening 
is important for prevention and/or earl detection of cancer, there is no guarantee that 
carriers will necessarily adopt appropriate screening behaviors following genetic testing. 
The few existing studies on behavioral tendencies post-genetic testing have found that 
most carriers follow recommended screening. Significantly, distress levels may 
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negatively impact adherence to recommended screening protocols, while greater social 
supports, the presence of open commun· cation patterns in families, and the sharing of 
genetic testing results with family physicians are likely to positively impact screening 
behaviors. 
Studies focusing on communicatio~ and disclosure patterns in HNPCC families have 
found that family dynamics seem to influence the target of communications and how 
much information is disclosed. Although there seems to be a greater tendency to disclose 
to those with closer ties to the individual, the information provided is often minimal. 
Interestingly, most individuals do not i entify a need for support from health care 
providers to help them with disclosure. 
Overall, the knowledge gaps surrob ding the factors influencing genetic testing 
uptake and positive movement throug the genetic testing process suggest the need for 
more theory to guide the content of and approaches taken during genetic counseling. 
Genetic counselors certainly need to be cognizant of how to relay information concerning 
HNPCC without increasing distress. As well, genetic counselors must take family 
communication patterns into consider tion when planning their sessions. 
Studies which have used standar ized instruments to measure distress levels and 
perception of risk have not been consistent in their ability to predict psychosocial and 
behavioral outcomes from genetic testing, yet this literature has been used to inform the 
practice of genetic counseling. It is b lieved that the insight gleaned from qualitative data 
I 
is more useful in designing instrume ts that will be able to detect the sensitive issues that 
emerge from living in families with a strong history of cancer. This knowledge can then 
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be used to develop social psychological I odels that will have greater explanatory power 
to inform the delivery of genetic services. 
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The pilot study was part of a larger study which is using a descriptive correlational 
design with longitudinal components to evelop, validate and evaluate monitoring tools 
for individuals with genetic-based diseases. The primary focus of the current study was 
on generating data to assess the psycho etric properties of the HD-GT scale. The content 
in this chapter is organized into two maj<Dr sections. The first section provides a brief 
overview of the construction of the scale content validation by the target population and 
experts, and scale readability. The secon section highlights the steps taken to evaluate 
the psychometrics of the HD-GT scale. 
Develop "'lent of the HD-GT 
Scale Development 
Items for the HD-GT were derived om data matrices formulated from a qualitative 
data base generated from interviews wit individuals (N = 39) comprising eight family 
groupings with a confirmed HNPCC pre&ence. The HD-GT is designed to elicit data on 
two major constructs from the substantiv theory, Confronting and Accepting the 
Challenges of Living in Families with G netic-Linked Diseases, emerging from the data 
analysis (Way et al., 2008). The constructs of interest for the pilot study include: a) living 
in families with a strong history of cancer, b) and becoming aware of genetic testing and 
living the process. 
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The item generation phase was COqipleted by a research team. This researcher was a 
member of the team. The process involved identifying potential item stems, reducing the 
number of item stems, reworking the ite text and finalizing it, and selecting the best 
rating scale format to use with this population. 
Initially, team members created a p ofile of frequency and priority ratings of 
properties and descriptors by individual ~articipant and family groups. Data for this 
process were obtained from five family groupings. To provide inter-rater reliability, the 
principal investigator (PI) reviewed a siX<th group in the same detail and validated the 
process. The remaining two groupings were subsequently reviewed for additional item 
stems. At the final stage, all items stems :were combined to give a total of 267. 
As item refinement proceeded, the emphasis was placed on conciseness and 
avoidance of negative wording, ambiguo s terminology, jargon, value-laden words and 
double-barreled questions. Multiple drafts of items were reviewed and modified by the 
team to increase clarity and diminish red ndancy. Following completion of this phase, a 
total of 68 items remained for potential i elusion in the HD-GT scale. 
The next step involved identifying suitable Likert rating scales for testing the 
usefulness of the items. Initially, consideration was given to using multiple scales that 
focused on: a) frequency of occurrence o select events/conditions (never, rarely, 
sometimes, often, and almost always), b) the importance/difficulty/receptiveness of 
specified events/conditions (not at all, a l'ttle bit, moderately, quite a bit, extremely), and 
c) how satisfied/ concerned/confident/certain one was with events/situations (not at all , a 
I 
little bit, moderately, quite a bit, extremely). The multiple selection options and anchors 
made item rating cumbersome. The decisl. on was subsequently made to rework the items 
to facilitate rating with one scale (not at all, a little bit, moderately, quite a bit, 
extremely). 
Content Validation 
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Two types of experts were used fo content validation. The HD-GT scale was first 
reviewed by two genetic counselors who work closely with individuals to prepare them 
for genetic testing and possible outcomes from this process. Genetic counselors were 
given a brief overview of the substantive theory, definitions and properties of the 
constructs and a copy of the scale. Input was first requested on the content relevancy 
(extremely, moderately, slightly, or irrel vant) of each item in terms ofits ability to 
measure the properties of each construct. Secondly, they were asked to rate the 
effectiveness (very, moderately, poorly o not at all effective) of the 5-point Likert rating 
scale (i.e., not at all, a little bit, moderately, quite a bit, extremely) for allowing 
participants to indicate the importance/u efulness of items representing individual 
properties. Overall, the content experts confirmed item-relevancy for measuring 
appropriate constructs and the usefulness of the Likert rating scale. Recommendations 
included minor content changes to select items and eliminating three redundant items, 
leaving the final scale with 65 items for the next step. 
The revised version of the HD-GT scale was subsequently content validated by two 
individuals (one carrier and one non-carrier ofHNPCC) who had participated in the 
qualitative study. These two individuals commented on item clarity and relevancy, as 
well as the usefulness of the rating scale. Difficulties in scale administration, ambiguities 
in wording and the time required to com~lete the task were noted and addressed. 
Scale Readability 
Steps were taken by the research team to ensure that the HD-GT scale was at an 
appropriate reading level for the target pbpulation. Because this scale was developed to 
assess the experiences of individuals wh have undergone predictive DNA testing for 
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colorectal cancer, they have been exposed to terms such as HNPCC, carriers/non-carriers, 
inherited, generations, hereditary, genetic and geneticist/genetic counselor. These 
polysyllabic words and others are used fi equently in the scale which does increase its 
final readability score. 
Several methods were applied to assess the readability of the scale, including the 
Flesch-Kincaid Grade Level and Flesch Reading Ease, SMOG (Simple measure of 
gobblegook) and the Fog Index (Readab· ity Formulas, n.d.). A grade less than 10 is 
recommended to ensure maximum readi g ease and material comprehension. The 
findings indicated that the readability level of the HD-GT met the criteria. 
Psychometric E aluation of the HD-GT 
Population and Sample 
The target population was individuals at 50% risk for inheriting HNPCC who had 
participated in predictive testing and wer informed of their carrier status. The goal was 
to recruit approximately equal numbers of carriers and non-carriers of the MSH2 
mutation. Survey respondents were recruited from population-based probands comprising 
the Provincial Medical Genetics Progr ofNewfoundland and Labrador. 
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Three large pedigrees with MSH2 utations on intron 5, exon 8 or exon 4 to 16 
have been identified. Immediately prior o the pilot study, 272 carriers and 295 non-
carriers had been confirmed from the Pr9vincial Medical Genetics Program of 
Newfoundland and Labrador and entered into a Cancer Screening Data Base. This data 
base was developed for a component ohhe larger study which is retrospectively profiling 
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the actual screening practices of carriers and non-carriers following genetic testing. The 
rationale for using this data base is that actual screening practices will be, ultimately, 
linked to the psychosocial and behaviora[ self-report data obtained over time following 
confirmation of the psychometric prope ies of the monitoring tools. 
At the time of the pilot study, the information available on registrants comprising 
the Cancer Screening Data Base was reviewed to identify potential participants. 
Registrants excluded from consideration included those who did not have a confirmed 
carrier status (i.e., obligate carriers, presilined positive, or inconclusive results with 
unknown risk), had not participated in g netic testing, had died since their name was 
entered into the data base, had no contac information, or had refused to be contacted for 
research purposes. This left the research earn with an initial list of 179 potential 
participants for the pilot study. Followin additional inquiries, this number declined to 
119 due to several factors (i.e., deceased, refused to review survey information to 
ascertain interest, family/personal distress, ill health, scheduled for surgery, living outside 
the province with no new contact information, or deemed to be mentally incompetent by 
a family member). Of the 119 individual contacted by either this researcher or the 
research assistant and agreed to review tqe study materials, 75 (45 carriers and 30 non-
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carriers) completed the survey at the ti e of the pilot study, resulting in a 63% response 
rate. 
Procedure 
Data collection commenced following receipt of ethical approval from the Human 
Investigation Committee, Faculty of Medicine, Memorial University as well as Eastern 
Health where the Provincial Medical Genetics Program ofNewfoundland and Labrador is 
located (Appendix B). The pilot study p ' ase spanned a three month time period from late 
February to late May 2008. 
Telephone contact was initiated w· h potential respondents to inform them about the 
study and ascertain their willingness to receive additional information. The telephone 
script followed by the interviewers can be found in Appendix C. Individuals indicating an 
initial interest were forwarded packages consisting of a cover letter, a brief summary of 
the study, two consent forms (Appendix D) and the survey instrument (Appendix E). 
Following receipt of the consent fd , a follow-up telephone call was made by two 
members of the research team (this rese cher and the research assistant) to determine the 
preferred mode of participation (face-to- ace or telephone) and to schedule a mutually 
agreed upon time for survey completion Some respondents returned the completed 
survey along with their consent forms. 
The rationale for presenting respo dents with optional modes for participating was 
based on the experience gained from im~lementing a previous quantitative study with this 
population (Way et al. , 2008). The earli r study highlighted numerous problems using a 
self- administration approach to data collection, including a large amount of missing data 
and inappropriate rating of certain items. This was true despite the fact that all of the 
scales used were designed for self-admi istration. Although face-to-face interviews are 
the preferred method to accommodate i ldividual differences (illiteracy, diminished 
vision, or other problems which might interfere with a person's ability to complete a 
I 
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scale), total reliance on this approach is not practical in terms of time and cost given the 
large geographic dispersion of the target population (Po lit & Beck, 2008). The pilot study 
was intended to provide additional data n the feasibility of using a mixed-methods 
approach with this population. 
HD-GTScale 
The original HD-GT scale had ten sections with a total of 65 items. The content of 
this scale is based on two constructs- living in families with a strong history of cancer, 
and becoming aware of genetic testing and living the process. The first construct was to 
be assessed by the 17 items in sections A 1 and A2 (Appendix E). Scale items in these two 
sections are intended to capture respondknts ' experiences with cancer and its treatment on 
a personal level and/or with family members, reactions to being informed about a 
possible MSH2 mutation within the fam'ly, and the impact on family relations. 
The second construct was to be assessed with 48 items in sections A3 to A10 of the 
HD-GT (Appendix E). Scale items are i tended to capture critical attitudes and feeling 
states at different junctures in the genetic testing process: a) lead-in period (motivation to 
participate, cognitive and emotional preparedness), b) during (desire to know test results, 
emotional difficulties while waiting, co I cems over others reluctance to participate), and 
c) post-test period (adequacy of supports while receiving results, understanding of risks, 
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awareness of family cancer patterns, personal/family communications/disclosure around 
HNPCC risk). 
Ethical Considerations 
Several steps were taken to protect participant rights in the current study. 
All individuals meeting the inclusion crJ eria were contacted by either this researcher or 
the research assistant. Individuals who akreed to participate were given three 
opportunities to consider their agreemen~ to participate in the project. First, all individuals 
were asked in the initial telephone call i they would like to participate. Those who 
agreed were then sent study materials (Appendix D & E) and were asked to complete the 
enclosed consent and forward it to the r search team in the return envelope provided. 
Returned consent forms were perused fo appropriate completion and then follow-up 
telephone contact initiated. Before proceeding to interview scheduling, the interviewer 
determined that potential respondents understood what they had consented to do and were 
still willing to proceed with the study. Tpis approach ensured that potential respondents 
were not subjected to coercion or undue influence. 
Confidentiality of all data has bee maintained by assigning a numerical code to all 
forms and instruments. A master list of ames and corresponding codes is being kept in a 
locked filing cabinet accessible only to he research team. 
Data Analysis 
Data were coded and entered into the Statistical Package for the Social Sciences 
(SPSS) for analysis. Descriptive statistJ s were used to create a profile of respondents' 
scores on all study instruments. Exploratory factor analysis was used to assess subscale 
structure. The initial factor solution and t arimax rotation failed to generate factors that 
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aligned with the proposed constructs oft e substantive theory in a meaningful way. This 
could be due, in part, to the small sample size. 
I 
As a result of the non-usefulness ofthe factor analysis procedure, a correlation 
matrix was generated of all HD-GT ite~s to search for item groupings as recommended 
by Ware and Gandek ( 1998). Projected ubscales were then constructed and their items 
evaluated for adherence to Likert scalin assumptions. At the first step, the assumption 
concerning the appropriateness of using articular items to create a summative score 
(approximate equivalence of means and ariances, use of all response choices in the 
rating scale, amount of missing data, an approximate symmetry in response distribution) 
were assessed. At the second step, a mu i-item/multi-trait correlation matrix was 
generated to assess three additional ass ptions (linearity, item-convergent validity and 
item-discriminant validity). At the final tep, subscale scores were assessed in terms of 
ceiling and floor effects, approximate s~mmetry, internal consistency and inter-
correlations. 
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CHAPTER4 
Results 
Study findings are presented in three sections. The first section presents a summary 
of the descriptive findings on the sample and HD-GT scale. The second section presents 
findings on the reliability and validity o the HD-GT scale. The final section presents a 
brief discussion on the study findings. 
Descriptive Profile 
Study findings are organized unde / six major subsections. First, a brief overview is 
presented on the personal characteristics (demographics and illness-related) of the 
sample. Second, the outcome of variant scale administration is presented. Third, the 
results are presented on the final subsc1 structure derived from inter-item correlation 
analyses. Fourth, a detailed summary is presented of the data quality and how well 
individual items met scaling assumptiot¥. The fifth subsection focuses on the subscales 
of the HD-GT and examines hypothesizl d item groupings in terms of internal 
consistency, equality of item-scale corrJlations, and item discriminant validity. The final 
subsection presents the findings on the subscale scores for the HD-GT. 
Personal Characteristics 
The sample for the pilot was comprised of75 respondents. The mean age was 52.82 
(SD = 13.69), with a range from 24 to 88 years. The majority of respondents were female 
(66.67%). 
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Table 1 summarizes illness-related characteristics of the sample. Most participants 
were carriers of the HNPCC gene (60%) but unaffected by cancer at the time of the study 
(55.56%). The dominant mutation type as the intron 5 splice site mutation (72%). Of 
those respondents who reported having J ad a bout of cancer (n = 21 ), the most 
predominant type was colon (61.90%) e"ther alone or in combination with other cancers. 
The vast majority of respondents (93 .33 o) were actively involved in cancer screening. 
HD-GT Scale Administration 
The HD-GT was administered to articipants in one of three ways: face-to-face, 
telephone or self-administered. Data cof pleteness was similar for all three methods, 
indicating that it is possible to administer this scale under variant conditions. 
Subscale Structure 
Following exploratory factor analjy'sis, all of the items for the conjectured theoretical 
factors were not lining up as expected. The decision was then made to generate a 
correlation matrix for all of the HD-G scale items. Each item was subsequently 
analyzed for the strength and signific, ce of its correlation with all other items. 
A table summary was constructed of items correlating with other items within the 
set cutoff ranges (i.e., >.40 and .30 to .40). This exercise was the primary basis for final 
selection of items for each subscale. The inclusion of other items not meeting these 
criteria was based on conceptual logic around item content for designated subscales based 
on the substantive theory. 
Table 1. Illness-Related Characteristics (N = 75) 
Carrier Status 
Carrier 
Cancer Presence - Yes 
Cancer Presence - No 
Non-carrier 
Cancer Presence - Yes 
Cancer Presence - No 
Mutation Type 
Intron 5 Splice Site 
Exon 8 Deletion 
Cancer Type 
Colon Only 
Reproductive Only 
Colon & Reproductive 
Colon & Other 
Other Only 
Cancer Screening 
Yes 
No 
n 
45 
20 
25 
30 
29 
54 
21 
5 
5 
3 
5 
3 
70 
5 
% 
60.00 
44.44 
55.56 
40.00 
03.33 
96.67 
72.00 
28.00 
23.81 
23.81 
14.29 
23 .81 
14.29 
93 .33 
06.67 
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Following completion of this stage of the analysis, 13 items fai led to correlate in a 
consistent manner with other items in terms of the set cut-off range. These items were 
subsequently removed, leaving the final version of the HD-GT scale with nine subscales 
comprised of 52 items. The subscales for the HD-GT and their item totals are 
summarized in Table 2. 
Data Quality and Item-level Summated kcale Assumptions 
Data Quality. A useful measure of data quality is the amount of missing data for 
each item and projected subscales of a summated rating scale (Ware & Gandek, 1998). 
Another component of data quality addresses the frequency distribution or spread of 
scores across the steps (response choices of a rating scale (Ware & Gandek). This 
information is examined for two reasons: 1) usefulness of all steps in a rating scale and, 
2) variability and symmetry of the data. 
Table 3 summarizes the findings for the 52 items and nine subscales of the HD-GT. 
I 
Missing data for individual items were random and minimal, ranging from 0% to 4%. 
Although there is no consensus on what onstitutes extensive missing data (from 10% -
40%) on any given item or variable, it is generally agreed that what is more important is 
whether the pattern is systematic or rand lm in nature (Fox-Wasylyshyn & El-Masri, 
2005). 
As well, the majority ofrespondents (74.67%) had complete data for all of the 
subscales of the HD-GT. The percent of espondents with complete data for individual 
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Table 2. Theoretical Constructs and HD-GT Subscales 
I 
Theoretical Constructs HD-C!JT Subscales 
Construct 1 - Living in Families Impact of Familial Cancer (IF C) - 9 items 
Construct 2 - Genetic Testing Fami~y Challenges Genetic Testing (FCGT) - 6 items 
Genetic Testing Preparation (GTP) - 9 items 
Wait ime Concerns (WC) - 6 items 
Supp rt for Genetic Testing Results (SGTR) - 5 items 
Understanding Risk (UR) - 5 items 
Transmission Beliefs (TB) - 4 items 
Cornryunications around Genetic Link (CGL) - 4 
items 
Disci sure Issues (DI) - 4 items 
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Table 3. HD-GT Data Quality and Item-level Descriptive Statistics 
Scale Items X SD Missing Response Values Frequency 
(%) 0 1 2 3 4 
Impact of Familial Cancer (IFC) 
• Cancers more frequent & at younger age (IFC 11 R) 1.25 1.36 4.0 28 20 11 4 9 
• Memories of cancer suffering (IFC 12 R) 1.03 1.25 2.7 35 16 12 5 5 
• Difficulty accepting cancer motivate to know (IFC 13 R) 1.37 1.35 2.7 27 14 18 6 8 
• Scary observing same cancer pattern (IFC 14 R) 1.01 1.33 2.7 38 15 7 7 6 
• Draining to lose members to cancer (IFC 15 R) 1.92 1.50 2.7 18 13 16 9 17 
• Cancer suffering/death worried about self (IFC 16 R) 1.75 1.45 2.7 21 10 22 6 14 
• Worry re multiple cancers in one member (IFC 1 7 R) 1.58 1.42 2.7 21 20 13 7 12 
• ..Stress-of cancer-altered family-relations--(IFe-18 R) 2.:-5-3 1.42- 2.7 M 14 t3 11 28 -
• Screening reminder of personal risk (IFC26 R) 1.86 1.47 2.7 20 9 20 9 15 
Family Challenges Genetic Testing (FCGT) 
• Genetic testing [GT] important for everyone (FCGT41) 3.68 0.85 1.3 2 1 3 7 61 
• Concerned about those who refuse GT (FCGT42) 3.09 1.21 1.3 4 6 8 17 39 
• Concern understand risk when refuse GT (FCGT43) 3.12 1.20 2.7 4 5 9 15 40 
• Refuse GT- fearful of knowing status (FCGT44) 3.34 1.08 2.7 4 2 4 18 45 
• Important everyone informed ofHNPCC (FCGT105) 3.85 0.56 0.0 1 0 1 5 68 
• Better knowing status than not knowing (FCGT76) 3.73 0.84 0.0 2 2 1 4 66 
Genetic Testing Preparation (GTP) 
• Timely GT info from genetic personnel (GTP31 ) 3.36 1.06 0.0 2 4 9 10 50 
• Adequate info about GT process (GTP32) 3.39 0.99 0.0 2 3 7 15 48 
• Important to know one's HNPCC status (GTP34) 3.36 1.08 1.3 2 5 7 10 50 
• Understand HNPCC risk and accept GT (GTP35) 3.58 0.74 1.3 0 1 8 12 53 
54 
• Help offspring to know HNPCC status (GTP36) 3.62 0.87 1.3 2 1 4 9 58 
• Need genetic personnel support during GT (GTP37) 3.07 1.28 2.7 6 5 6 17 39 
• Need support from family/friends (GTP38) 3.37 0.99 0.0 3 1 7 18 46 
• Relieved study investigating familial mutation (GTP23) 3.14 1.12 4.0 2 5 13 13 39 
• Positive attitude toward GT (GTP24) 3.55 0.86 1.3 0 5 3 12 54 
Wait-Time Concerns (WC) 
• Trying time thinking about HNPCC status (WC51 R) 2.03 1.48 1.3 17 13 10 19 15 
• Not prepared for long wait for GT results (WC52 R) 2.65 1.43 0.0 8 12 9 15 31 
• Uncertain about medium for results receipt (WC53 R) 3.07 1.32 0.0 5 7 11 7 45 
• Dwelling on reaction to GT results (WC54 R) 2.43 1.39 0.0 8 15 12 17 23 
• Question ability to understand GT results (WC55 R) 2.59 1.44 0.0 9 11 12 13 30 
• Geneticist contact increased perceived risk (WC22 R) 1.70 1.55 2.7 23 15 13 5 17 
Support for Genetic Testing Results (SGTR) 
• Family/friend present (SGTR61) 2.32 1.56 0.0 16 9 10 15 25 
• Call from genetic personnel prior to receipt (SGTR62) 2.01 1.57 1.3 21 9 10 16 18 
• Face to face contact to receive results (SGTR63) 2.53 1.49 0.0 12 7 15 11 30 
• Receive letter explaining HNPCC status (SGTR64) 3.28 1.17 0.0 5 3 4 17 46 
• Follow-up important re lifestyle/screening (SGTR75) 2.41 1.51 1.3 14 8 10 18 24 
Understanding Risk (UR) 
• Regular screening for cancer detection (UR82) 3.83 0.50 4.0 0 1 1 7 63 
• Appropriate screening timely cancer detection (UR83) 3.89 0.36 2.7 0 0 1 6 66 
• Early detection improve disease management (UR84) 3.88 0.37 2.7 0 0 1 7 65 
• Healthy living/positive attitude improve QOL (UR85) 3.55 0.86 1.3 2 0 6 13 53 
• Self-responsible for healthy living/screening (UR86) 3.82 0.59 2.7 1 0 1 7 64 
Transmission Belief (TB) 
• Younger age first HNPCC cancer (TB91) 3.01 1.27 2.7 7 3 7 
• Men/women different type fust cancer (TB92) 2.37 1.34 2.7 12 4 18 
• Different types cancer today than before (TB93) 2.45 1.38 1.3 11 6 17 
• Greater numbers of family members with cancer than before 2.38 1.32 1.3 10 7 20 
(TB94) 
Communication around Genetic Link (CGL) 
• Young people open to HNPCC info (CGL103) 2.84 1.12 1.3 5 3 14 
• Young people understand own HNPCC risk (CGL104) 2.74 1.15 2.7 5 5 15 
• All family open to HNPCC info (CGL107) 3.08 1.03 1.3 1 4 18 
• -All family understand own HNPCE-risk-(C6L10-8} f-3 .11 0.95 1-:3 - 1 3 15 
Disclosure Issues (DI) 
• Difficult inform young people about HNPCC risk (DI102) 2.67 1.41 0.0 9 9 9 
• Difficult inform family members about HNPCC risk (DI 1 06) 2.23 1.57 1.3 19 5 11 
• Genetic personnel guidance needed to inform (DI109) 2.78 1.40 1.3 8 8 9 
• Protect rights of others relating HNPCC risk (DI 11 0) 3.35 1.07 0.0 4 0 10 
Note: 1) Response choice values are: 0 = Not at all; 1 = A little bit; 2 =Moderately; 3 = Quite a bit; 4 = Extremely. 
2) Items with the designate_ R are reverse scored. 
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subscales ranged from 89.33% for the P to 97.33% for the SGTR and DI (data not 
shown). The minimum and random amo nt of missing data for this pilot study suggests 
that overall the scale items were not difficult to understand or interpret (Ware & Gandek, 
1998). 
The findings also suggest that th re were minimal issues with interpreting the 
response choices. All response choices were used for most items (82.70%). The data also 
depict wide variability across the rating ~cale and approximate a symmetrical distribution. 
The subscale items with minimal to no use of certain response choices were expected. 
That is, most individuals are expected to attach high importance to being adequately 
prepared for genetic testing (GTP), to understand their cancer risk (UR), to belong to 
families that openly communicate about he genetic disease risk (CGL), and to experience 
few difficulties informing other members about their potential risk (DI). 
Item-level scaling assumptions. TJ is section examines the patterns observed with 
item means and standard deviations for each hypothesized subscale of the HD-GT. Items 
means and standard deviations within ea<Ch subscale are approximately equivalent (Table 
3). There are important exceptions howe er which require further elaboration. In the IFC 
subscale, items 15, 16, 18 and 26 have hi her mean scores and greater variance than the 
remaining items. This finding is expected given that these items are more focused on 
assessing feeling states and perceived implications for the self. 
The higher mean scores and lower ariances observed for items 41 , 105 and 76 
comprising the FCGT subscale were also expected since their content focuses on the 
importance of genetic testing for everyo~l presumed to be at high risk for cancer. As 
well, the lower mean scores for items 37 d 62 in the GTP and SGTR subscales, 
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respectively, are expected because note eryone needs ongoing support from the 
geneticist/genetic counselor throughout the genetic testing process or expects a call prior 
to receiving their results. Finally, the hi her mean scores for items 53, 64, 91 and 110 
from the WC, SGTR, TB and DI subsca,es, respectively, were also expected. That is, it is 
normal to experience uncertainty about he medium to be used for conveying results 
(WC) and everyone expects to receive a letter detailing the information conveyed 
regarding their results (SGTR). As well, the evidence in local, national and international 
families indicate that the age for first on j et ofHNPCC is declining (TB) and there are 
more concerns today about protecting th rights of others (DI) (Lynch & de la Chapelle, 
2003; Lynch et al. , 2008; Merg et al. , 2005; Stuckless et al. , 2007). 
Scale Level Assumptions 
Following construction of the proposed scales, a second correlation matrix was 
generated of all items and projected subscales. In addition to this multi-trait/multi-item 
correlation matrix, internal consistency was generated for each subscale to derive the 
corrected item-total correlations. All of tpese steps were necessary to determine the best 
subscale for individual items. Table 4 contains a summary of these findings which 
provide support for the Likert scaling asr ptions (i.e., item internal consistency, 
equality of item-scale correlations and it~m discriminant validity) as discussed in the 
following sections. 
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Table 4. Correlation Matrix of HD-GT Items with each Subscale 
Scale Pearson Item Scale Correlation (*Corrected) 
X SD IFC FCGT GTP WC SGTR UR TB CGL DI 
• IFCll R 1.25 1.36 0.64* 0.10 0.27 0.21 0.20 0.22 0.38 0.37 0.13 
0.39 0.67* 0.50 0.48 
0.64* 0.41 
3.34 0.61 * 0.37 
3.73 0.44* 0.10 
• FCGT 105 3.85 0.56 0.44 0.53* 0.61 
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Scale Pearson Item Scale Correlation (*Corrected) 
X SD IFC FCGT GTP WC SGTR UR TB CGL DI 
Genetic Testing Preparation 
0.32 
• WC22 R 1.70 1.55 0.41 0.43 0.29 0.54* 0.24 0.15 0.27 0.40 
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Scale Pearson Item Scale Correlation (*Corrected) 
X SD IFC FCGT GTP WC SGTR UR TB CGL DI 
• SGTR61 2.32 1.56 0.29 0.34 0.42 0.45 0.70* 0.26 0.16 0.23 0.46 
• SGTR75 2.40 1.50 0.26 0.41 0.43 0.34 0.56* 0.24 0.31 0.14 0.27 
Scale Pearson Item Scale Correlation (*Corrected) 
X SD IFC FCGT GTP WC SGTR UR TB CGL DI 
• TB91 3.01 1.27 0.42 0.29 0.01 0.29 0.26 0.00 0.65* 0.28 0.16 
• TB93 2.45 1.37 0.34 0.27 0.15 0.41 0.26 0.26 0.62* 0.31 0.26 
Communication around Genetic 
Link 
• DI102 2.67 1.40 0.25 0.21 0.30 0.43 0.37 0.12 0.19 0.20 0.66* 
Note: IFC = Impact of Familial Cancer; FCGT = Family Challenges Genetic Testing; GTP = Genetic Testing Preparation; WC = 
Wait-Time Concerns; SGTR = Support for Genetic Testing Results; UR = Understanding Risk; TB = Transmission Beliefs; CGL = 
Communication around Genetic Link; DI = Disclosure Issues. 
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Item internal consistency. Item i ternal consistency assesses the degree to which an 
item correlates with its scale score in a substantive, linear fashion. Such correlations are 
derived by excluding relevant items fror,n their intended scales, calculating scale scores 
from remaining items, and then correlatmg removed items with the new scale scores. This 
corrected item-total correlation reduces · nflation levels and can be generated in SPSS by 
the Cronbach's alpha procedure for reli bility. Corrected item-total correlations for 
individual items and their subscales are ighlighted by an asterisk in Table 4. 
As shown in Table 4, the corrected correlation of items with their respective scales 
was greater than .40 for the most part. 'T1he only exception was item 24 of the GTP 
subscale which fell within the .30 and .40 range. This item measures motivation to 
become involved in genetic testing prio~ to actually doing so and is therefore an 
important factor in the entire process. 
Overall the findings support the presence of substantial correlations between HD-
GT items and their hypothesized scales. Thus, the data fulfill the criteria for the item 
internal consistency assumption. 
Equality of item-scale correlatio+ This assumption addresses the proximity of 
values for all of the item-scale correlations within a hypothesized scale. The best scale 
I 
contains item-scale correlations that are roughly equal and ideally fall within the .40 to 
.70 range (Ware & Gandek, 1998). The I eader is again referred to the corrected item-total 
correlations for individual items and the"r subscales in the columns with asterisks in 
Table 4. 
For the majority of HD-GT subscales, the corrected-item total correlations fall 
within an acceptable range. There ares me exceptions however. The items that appear to 
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be contributing more to their various scales than other items include items 14 and 16 of 
the IFC subscale, items 51 and 54 of the WC subscale, and items 104 and 108 from the 
CGL. It is interesting that these items e dealing with emotional content which may be 
responsible for the observed discrepanc es. The other subscale evidencing variable 
contributions of items to the scale score is the GTP. This finding is expected to a degree 
since item content is focused on differe t aspects of the genetic testing process (i.e. , 
importance of adequate and timely infoflation versus importance of knowing and 
understanding versus the importance ofhaving adequate supports and being emotionally 
prepared for genetic testing). 
It is important to note that correlan· ons are only one factor to consider when placing 
items in a particular scale. There are also content implications of particular items which 
must be considered when decisions are b ade about their retention or exclusion from a 
scale. Finally, current findings are based on data obtained from a small sample. 
Item discriminant validity. This assumption takes the logic of equality of item-
scale correlations (magnitude of correla ion with hypothesized scale) a step further to 
examine the strength of item correlations with other scales in a matrix that it is not 
intended to measure. In this case, the objective is for each item to have a stronger 
I 
correlation with its hypothesized scale than with related scales comprising a matrix. 
Study findings for the HD-GT ares l arized in Table 4. 
For the most part, the HD-GT iteJ s evidenced good discriminatory power across 
the subscales. The exceptions were ite s 105 and 41 ofthe FCGT subscale, items 24 and 
37 ofthe GTP subscale, item 86 ofthe UR subscale and item 109 ofthe DI subscale. 
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Scale Level Descriptive Statistics 
Total subscale scores were const cted for each participant following confirmation 
of item scaling assumptions. Considera ion was first given to the impact of select sample 
characteristics on subscale scores. At tqe second step, the properties of the subscales were 
examined with special attention given to the logic of mean and standard deviation scores. 
Table 5 summarizes the subscale score or carriers and non-carriers but not the total 
sample. 
Comparability of scale scores. It as hypothesized that subscale means should be 
approximately equal within the sample based on demographic and illness-related 
characteristics. The reader is reminded hat two of the subscales, IFC and WC, are 
reversed scored. The t-test of differenc and correlation tests assessed the impact of select 
factors on subscale scores. No significant effect was detected for exon type, cancer 
presence, gender or age (p > .05) (data not shown). 
The IFC, FCGT and CGL subscales evidenced significant differences for HNPCC 
status (p < .05). Table 5 summarizes tJese findings. Specifically, carriers more so than 
non-carriers reported less impact of fj ily cancer on genetic testing decision-making 
(IFC) but attached greater importance ~o having at-risk family members participate in 
genetic testing (FCGT). As well, carrit s perceived family members to be less open to 
and accepting of information about HNPCC than non-carriers. 
Scale properties. Subscale me~, standard deviations, lowest and highest scores 
and score ranges were examined for b th raw and transformed scores. The focus here was 
on the logic behind the distribution o~ subscale scores. 
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Table 5. HD-GT Subscale Scores by HNPCC Status 
Subscales Rj ge Carriers Non-Carriers t 
M M 
I (SD) (SD) 
Impact of Familial Cancer (IFC) 0-36 16.37 11.71 2.13 
(9.75) (7.66) (p=.036) 
Family Challenges Genetic 0-28 19.95 22.51 -3.09 
Testing (FCGT) (4.87) (1 .99) (p=.003) 
Genetic Testing Preparation 0-36 30.08 31.46 -0.82 
(GTP) (7.30) (6.15) (p=.416) 
Wait time Concerns (WC) 0-24 15.57 12.67 1.85 
(6.6) (6.49) (p=.068) 
Support for Genetic Testing 0-20 12.14 13.10 -0.71 
Results (SGTR) (6.21) (4.75) (p=.479) 
Understanding Risk (UR) 0-20 18.80 19.25 -0.91 
(2.25) (1.71) (p=.364) 
Transmission Beliefs (TB) 0-16 9.77 10.64 -0.93 
(3 .86) (3.84) (p=.354) 
Communication around Genetic 0-16 11.0 13.19 -2.82 
Link (CGL) 
I 
(3.83) (2.72) (p=.006) 
Disclosure Issues (DI) ol l6 10.58 11.68 -1.08 
(4.34) (4.12) (p=.286) 
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For most subscales, higher sco es are reflective of greater importance, 
understanding, awareness, and openness and acceptance. The exceptions are the 
I 
reverse scored IFC and WC where higher scores reflect less impact of familial 
cancer and less wait-time emotional challenges, respectively. 
The pattern of mean scores and standard deviations for each subscale is 
summarized in Table 6. The low to ~oderate mean score for IFC indicates that 
familial cancer history had a significant impact on genetic testing decision-making. 
The high mean scores for FCGT and GTP suggest that great importance was 
attached to having at-risk family me bers participate in genetic testing and to be 
adequately informed and emotionally prepared for this process. The moderate mean 
score for WC indicates that a fair number of respondents were challenged 
emotionally while waiting for genetic testing results. Comparatively, the moderate 
mean score for SGTR suggests that not everyone attaches high importance to having 
family and/or health care providers present during receipt of genetic testing results. 
The UR has a relatively high mean score which is significant since this suggests that 
I 
most respondents understood the importance of regular screening and healthy 
lifestyles. The three remaining scales - TB, CGL and DI - have mean scores that 
fall within the moderate to high range. These findings suggest that one-third to one-
quarter of respondents did not have a complete picture of cancer profiles in the 
family or perceive that family members of all ages were open to and accepting of 
HNPCC information, and encountered some difficulties around disclosure. 
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Table 6. Descriptive Statistics for Raw and Transformed Subscale Scores of the HD-GT Scale 
Raw Scores 
Observed/Possible Values Floor(%) Ceiling(%) 
Subscale Mean SD Lowest Highest Range 
Impact of Familial Cancer (IFC) 14.53 9.21 0/0 36/36 36/36 1.4 2.8 
Family Challenges Genetic Testing (FCGT) 20.99 4.15 4/0 24/24 20/28 1.4 36.1 
Genetic Testing Preparation (GTP) 30.66 6.83 5/0 36/36 31/36 1.5 29.9 
Wait-Time Concerns (WC) 14.36 6.67 0/0 24/24 24/24 1.4 6.9 
Support for Genetic Testing Results (SGTR) 12.52 5.66 0/0 20/20 20/20 4.1 11.0 
Understanding Risk (UR) 18.97 2.06 1110 20/20 9/20 1.4 70.8 
Transmission Beliefs (TB) 9.73 3.99 0/0 16/16 16/ 16 2.8 6.9 
Communications around Genetic Link (CGL) 11.82 3.60 0/0 16/16 16/ 16 1.4 15.3 
-
Disclosure Issues ffil) 11 .00 4.26" - o;o ~6'710 16116 1.4 17.8 
Transformed Scores (0-100) 
Observed/Possible Values Floor(%) Ceiling(%) 
Subscale Mean SD Lowest Highest Range 
IFC 40.38 25 .59 0/0 100/1 00 100.00/1 00 1.4 2.8 
FCGT 87.44 17.29 16.67/0 100/100 83.33/100 1.4 36.1 
GTP 85 .16 18.96 13.89/0 100/100 86.111100 1.5 29.9 
we 59.84 27.79 0/0 I 00/ 100 100.00/100 1.4 6.9 
SGTR 62.60 28.30 010 100/ 100 100.001100 4.1 11.0 
UR 94.86 10.28 55.00/0 100/ 100 45.00/100 1.4 70.8 
TB 63.19 24.07 0/0 10011 00 100.00/100 2.8 6.9 
CGL 73.87 22.48 010 100/100 100.00/ 100 1.4 15.3 
01 68.75 26.62 0/0 100/100 100.00/ 100 1.4 17.8 
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Table 6 also presents study find'ngs on the variability of the subscale scores and the 
proportion of respondents scoring at tlhe floor and ceiling levels. The rating scale values 
ranged from 0 (not at all) to 4 (extremely) or 0 to 100 (transformed scores) for all 
subscales with the exception of IFC a d WC which were reverse scored. In the reversed 
scored scales the values are also reversed (0 = extremely and 4 = not at all). Six out of 
nine subscales had a complete range o scores. The scales without the full range (FCGT, 
GTP and UR) had higher mean scores and lower variability. Overall, the subscale scores 
evidenced fairly substantial variability, 
Ceiling and floor effects demonstrated that most scales had a full range of scores. 
Specifically, the findings indicate that $even of the nine subscales had less than or equal 
to 1.5% of respondents at the floor. In general, there was a higher percent of respondents 
scoring at the ceiling than the floor, the exceptions again were the scales with reverse 
scoring (i.e. , 4 = not at all; 0 = extremeby). Ceiling effects were highest for the UR scale 
which is expected given its importance for behavioral change that is required based on 
one's HNPCC status (i.e., carrier versus non-carrier). 
Reliability and Validity of HD-GT Scale 
The reliability and validity of the subscales of the HD-GT were examined in the 
current study. Cronbach's alpha coefficient was used to assess internal consistency. 
I 
Correlations among the subscales are useful preliminary measures of the construct 
validity of the entire scale. These findings are summarized in Table 7. 
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Table 7. HD-GT- Correlations and Internal Consistenc/ (N = 75) 
Scale IFC FCGT GTP we SGTR UR TB CGL DI 
IFC (.89) 
FCGT -.37b (.81) 
GTP -.41 b .55 a (.91) 
we .45a -.49a -.45a (.86) 
SGTR -.42a .52 a .598 -.54a (.83) 
UR -.24c .38b .58 a -.B 1 b .37b (.77) 
TB -.57a .35b .13 -.48a .36b .13 (.70) 
CGL -.58a .44a .33b -. ~9b .32b .25c .38b (.87) 
DI -.25c .26c .33b -.55a .so a .17 .27c .1 1' (.78) 
Note: IFC = Impact of Familial Cancer· FCGT =Family Challenges Genetic Testing; 
GTP = Genetic Testing Preparation; WC = Wait-Time Concerns; SGTR = Support for 
Genetic Testing Results; UR =Understanding Risk; TB =Transmission Beliefs; CGL = 
Communication around Genetic Link; 91 = Disclosure Issues. 
1Cronbach's alpha coefficient is bracke~ed in the diagonal. 
Alpha coefficients for the nine subscales were at or above recommended levels 
ranging from a low of . 70 for the TB subscale to a high of .91 for the GTP subscale. 
These findings suggest that all of the subscales have good internal consistency. 
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The magnitude and significance of correlations among the components of a scale 
are used to denote the distinctiveness of each component. At the first step, consideration 
is given to the pattern of correlations among the subscales. At the second step, the focus 
shifts to the comparability of the size of correlations among scales to each subscale' s 
internal consistency. 
The subscales of the HD-GT depict significant low to moderate, positive 
correlations with each other except for IFe and we. The subscales IFe and We 
negatively correlate with all other subscales as expected for reverse scored scales. That is 
lower impact of familial cancer and less wait-time emotional challenges are associated 
with greater importance given to genetic testing and being emotionally and cognitively 
prepared, being supported by family members and health care providers while receiving 
results, understanding the positive implications of regular screening and healthy living, 
being aware of the profile of cancer in the family, having all at-risk family members open 
to and accepting of HNPee information, and encountering few difficulties in telling 
others about HNPee risks. 
One final noteworthy point relates to the size or magnitude of the correlation 
between two subscales in comparison to the internal consistency value for each of them. 
As indicated by the findings in Table 7, all of the alpha coefficients are much larger than 
any Pearson' s r value. This finding alon with the significant inter-correlations noted 
above support the premise that each subscale is measuring something unique and 
therefore makes a distinct contributi n to the overall HD-GT scale. 
Discussion 
This pilot study was designed to collect baseline data on the HD-GT for the 
purpose of conducting a preliminary ~xamination of the psychometric properties of this 
scale. Study findings provide strong support for the high quality of the data collected 
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from the targeted population. That is, there was minimal missing data and an acceptable 
use of response choices comprising th rating scale for most items. As well, the findings 
provide good support for the item-leve~ scaling assumptions. The variations noted in 
certain subscale means and deviations were expected for the most part and can be 
attributed to item content deviations designed to capture the full range of the variable 
being measured. 
Study findings also provide strong support for item-scale assumptions. The item 
internal consistency was met with all items to hypothesized scale correlations >.40 with 
one exception. As well, most item-scale correlations fell within the .40 to . 70 range with 
some notable exceptions, providing gen ral support for the item-scale correlation 
assumption. Finally, the findings provide good support for the item discriminant validity 
assumption. That is, most items evidenc I d stronger correlations with their hypothesized 
subscales than other subscales comprising the HD-GT scale. It is anticipated that a larger 
sample size within the larger study will address some of the concerns around the equality 
of item-scale correlation and item discriminant validity assumptions. 
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With regard to scale properties, the distribution of subscale scores followed a 
logical pattern based on theoretical s ppositions, evidenced good variability, and had 
acceptable floor and ceiling effects. s well, reliability findings provide strong support 
for the internal consistency of each s bscale. Finally, the statistically, significant low to 
mid-range correlations among the subscales and their lesser value than corresponding 
alpha coefficients provide tentative support for the subscales distinctiveness and construct 
validity. 
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CHAPTERS 
Discussion 
The current pilot study examined the psychometric properties of the newly 
developed HD-GT scale. This chapter begins with a discussion of the psychometric 
properties of the HD-GT in relation to the literature and is followed by a discussion of the 
content of the subscales. Where applicable, findings are compared and contrasted to the 
existing literature. 
\ 
Psychometric Properties 
The approach to scale development and testing presented in Chapter 4 was based on 
the work of Ware and Gandek (1998). Other researchers have used the methodological 
approach suggested by these authors ( adwin, Alster, & Rubin, 2003; Radwin, Wascho, 
Suchy, & Tyman, 2005). It appears that this is a very acceptable method for evaluating 
the psychometric properties of scales. 
Sample and Target Population 
The target population was individuals from high and intermediate risk families 
registered in the Provincial Medical Gen tics Program of Newfoundland and Labrador 
who had completed predictive DNA test1 g for HNPCC. The personal characteristics of 
pilot study respondents were similar to th,ose of an earlier quantitative study based on a 
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sample derived from this registry (Way et al., 2008). Both samples appear to be 
representative of the target populatio . 
For both the earlier quantitative study and the current study, the majority of 
respondents were female, HNPCC carriers, and unaffected by cancer. Colon cancer was 
the dominant type for those individua s who reported having cancer. The mean ages and 
age range were also similar in the tw studies. Survey respondents in both studies were 
primarily of the intron 5 splice site m tation type. The vast majority of respondents in 
both studies were actively involved in cancer screening. 
Scale Administration 
Previous experience with this population had suggested that there could be issues 
with a self-administration approach to ata collection (Way et al. , 2008). Based on this 
knowledge, the research team decided hat the respondents should be given a choice of 
face-to-face completion with an interviewer, telephone administration with an 
interviewer, or self-administration of the scale. All three options were utilized and data 
completeness was similar, regardless o the presence or absence of interviewer support. It 
can therefore be concluded that this sea e is appropriate for utilization under variant 
conditions (Polit & Beck, 2008; Streine \ & Norman, 2003). 
Subscale Structure 
The subscale structures were created based on a number of methods. Initially, 
exploratory factor analysis was utilized but failed to produce factors that supported the 
constructs of the substantive theory. This led to the generation of a correlation matrix for 
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all of the subscale items in which each item was analyzed for the strength and 
significance of its correlation with all other items. This approach allows a number of 
assumptions to be examined concurrently such as item internal consistency, equality of 
item-scale correlation and item discriminant validity (Ware & Gandek, 1998). These 
assumptions help establish the suitability of including an item in a particular scale (Ware 
& Gandek). In addition, conceptual logic was utilized for inclusion of some items based 
on the constructs of the substantive th ory. This concept is supported by several authors, 
I 
especially given the relatively small sample size for the pilot (Radwin et al. , 2003, 2005; 
Ware & Gandek). The result of these methods was that the HD-GT scale has nine 
subscales containing 52 items. I 
Data Quality and Item-Level Scaling 1-ssumptions 
Ware and Gandek (1998) summat;ize key steps to follow for testing data quality and 
item-level scaling assumptions. Data quality involves examining the extent of missing 
data combined with the frequency distribution or spread of scores across the response 
choices of a rating scale. Item-level scal'ng assumptions refer to the pattern observed in 
the spread of item means and standard deviations within each individual subscale. 
I 
In accordance with the guidelines for data quality, a large amount of missing data 
for specific items may be indicative of llljlderstanding and/or interpreting problems. The 
current study evidenced minimal missin \ data with most respondents having complete 
data for all ofthe HD-GT subscales. Thi low percentage of missing data can be 
attributed to a number of factors. First, many of the respondents had been living in 
HNPCC families for quite a while and ha9 participated in related research. Thus, 
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familiarity with the terminology wo ld have facilitated understanding and interpretation 
of the statements. Second, the readability of the scales was at an acceptable grade level 
(less than 1 0) for survey research (Readability Formulas, n.d.; Streiner & Norman, 2003). 
Study findings also indicated that respondents had minimal issues with interpreting 
the response choices given that all of the steps (anchors) were used for most items. 
According to Ware and Gandek (1998), this finding indicates good data quality. 
With regard to item-level scalinl assumptions, the proposed guidelines suggest that 
items means and standard deviations should be fairly comparable within a given subscale 
(Ware & Gandek, 1998). This assump ion held for most subscales of the HD-GT. Item 
means and corresponding standard dev~ations demonstrating the greatest difference from 
subscale norms could be due to expected variations in individual level emotional 
responses to targeted content areas. Ware and Gandek note that this is an acceptable level 
of deviation for items dealing with emotional content and/or perceived support needs. 
Scale Level Assumptions I 
Item internal consistency, equality of item-scale correlations and item discriminant 
validity were the Likert scaling assumptions used to assess the HD-GT. The findings 
suggest that the subscales of the HD-GT fulfill the criteria for the Likert scaling 
assumptions. 
Item internal consistency, for the most part, fell within the proposed guidelines by 
Ware and Gandek (1998). Those items t at fell below the selected ~ .40 cutoff for 
inclusion in a particular subscale, and/or evidenced higher correlations with related 
subscales, were retained because they were needed to strengthen the overall content 
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validity of the specified subscale. T is is an acceptable practice in the early stages of 
scale development (Ware & Gandek). 
With regard to equality of item-scale correlations, there were several exceptions to 
the requirement that each item contribute approximately equal amounts to the total 
subscale. The items in question were hose addressing emotional content which may have 
been responsible for the observed dis repancies. For example, items 14 and 16 of the IFC 
subscale deal with the stress associated with family cancer patterns, suffering and early 
I 
deaths. The decision was made to keep these and other items because of their important 
theoretical content. According to the literature, families with hereditary cancers 
experience conflicting emotions as the struggle with multiple losses and search for 
meaning and understanding of causal£ ctors involved with the disease (Carlsson & 
Nilbert, 2007; Codori eta!., 2001; Jarv·nen eta!., 2000; Lerman eta!., 1996). 
Finally, the item discriminant validity assumption held for most subscales of the 
HD-GT. On a few occasions, a particular item did evidence equal to or greater than 
correlations with subscales other than tHe one intended. However, the internal consistency 
values for the subscales in question wer very good to excellent and the number of scale 
items acceptable. One possible factor re ponsible for the observed deviations from this 
assumption is the study's small sample s;ze. As Ware and Gandek (1998) note more 
vigorous testing in similar and/or larger samples is needed to finalize item inclusion or 
exclusion. Thus, it would be premature ith a pilot study to remove questionable items. 
\ 
\ 
\ 
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Scale Level Descriptive Statistics 
Ware and Gandek (1998) recommend examining summated rating scales for 
equivalency of mean and standard dl iation scores within comparable samples. A second 
important consideration for subscale cores is the observed pattern across the response 
choices (floor and ceiling effects). 
When subscale scores were assessed for approximate equivalency by using 
meaningful pilot sample subdivisions (carrier status, cancer presence, gender and age), 
some differences were observed betw en carriers and non-carriers of HNPCC. It could be 
argued that these findings are due to the variability in the psycho-emotional challenges 
facing the two groups. More important! y, despite the statistical differences in certain 
scores, the two groups paralleled each ther in terms of general understanding, attitude 
and feeling levels. From this perspecti 
1
e, a tentative conclusion from the pilot study is 
that the observed differences are not of a substantial nature. This finding supports 
previous findings by Heshka et al. (2008). These authors found in a systematic review of 
existing studies that there was no significant impact on psychological outcomes in either 
carriers or non-carriers as a result of ge etic testing. This study also reported no 
significant differences in risk perceptions of both groups at 12 months. Meiser (2005) 
also reported that the studies on HNPCC groups consistently found that carriers had only 
temporary increases in generalized anxiety immediately following disclosure of their test 
results and that non-carriers have no adverse long-term effects as a result of having 
genetic testing. I 
\ 
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Reliability and Validity of the HD-GT Subscales 
I 
Following construction of the subscales and examination of their adherence to item-
level and scale-level assumptions, c nsideration was given to reliability and validity 
issues. Preliminary findings indicate that the subscales of the HD-GT are both valid and 
reliable. 
Cronbach's alpha coefficient (s used to assess the internal consistency of each 
subscale. The alpha coefficients for ~he nine subscales were found to be at or above 
recommended levels. These prelimidary findings suggest that all of the subscales have 
good internal consistency (Polit & B ck, 2008). 
Calculation of inter-correlations among the subscales is recommended as an initial 
step in assessing the construct validi~ ofthe entire scale. The subscales of the HD-GT 
have significant low to moderate, positive correlations with each other, except for those 
reverse scored (IFC and WC). A maj r premise of the model from which the HD-GT was 
developed is that living in families with a strong history of hereditary cancer (construct 
one) influences how well individuals accept the hereditary link to cancer and are 
motivated to become involved in genetic testing. It is argued that this context is important 
because it influences the individual's thought processes and impacts integration of and 
adjustment to the facts on emotional d behavioral levels (Way et al. , 2008). Therefore, 
it was expected that the subscales oft e HD-GT would correlate well with each other. 
Interpretation of Subscale Scores 
I 
The various subscales developeq and tested in this pilot study compare favorably 
with what is already reported in the liJerature and also provide new insights into the 
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psychosocial and behavioral impact of genetic testing on individuals and families with 
HNPCC. By developing the HD-G from a qualitative data base, the content is steeped in 
the personal experiences of individuals from HNPCC families. Various authors argue that 
instrument item-content generated from qualitative data is more likely to capture the 
experiences of targeted groups (Coy e & Williams, 2000; McAllister, 2001 ). It is also 
argued that clinical tools developed in this manner have better content and face validity 
and excellent psychometric propertie (Gilgun, 2004). A discussion of the HD-GT 
subscales in terms of what they were designed to measure and how this relates to 
previous research findings in this area is provided in the following paragraphs. 
The HD-GT scale is designed to measure two constructs, living in families with a 
strong history of hereditary cancer, and becoming aware of genetic testing and living the 
process, ofthe substantive theory, Confronting and Accepting the Challenges of Living in 
Families with Genetic-Linked Diseas s. The construct, living in families with a strong 
history of hereditary cancer, is primarily measured by the first subscale which assesses 
the impact of a family history of cancer on genetic testing decision-making (IFC). 
The low scores observed with th IFC suggest that the family 's history of cancer 
has a significant impact on genetic tes ing decision-making. This finding supports 
previous research findings on the impo ance of a pervasive cancer presence for 
motivating people to seek genetic testi g (Bleiker et al. , 2003; d ' Agincourt-Canning, 
2005; Hadley et al. , 2003 ; McAllister, 2002, 2003; Pieterse eta!., 2005). Study findings 
also suggest that the experience of livi g in these families shape individuals ' 
understanding of personal cancer risk. upport for this finding is also found in the 
literature (Bleiker eta!., 2003; Codori eta!. , 1999; d ' Agincourt-Canning, 2005; Hadley 
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et al., 2003; McAllister, 2002, 2003 Pieterse et al., 2005). Finally, several researchers 
report that individuals within high-r sk families commonly overestimate their risk for 
developing the disease (Balmana et al., 2004; Bleiker et al., 2003; Braithwaite et al., 
2004; McAllister, 2002). 
The second construct, becoming aware of genetic testing and living the process, is 
measured by eight subscales of the HD-GT. The first subscale measuring this construct 
(FCGT) deals with the challenges faded by family members in decision-making around 
I 
genetic testing. The high scores fort is subscale suggest that survey respondents placed 
high value on having all potentially a -risk family members participate in genetic testing 
but were challenged by facilitating th ir acceptance of it. The items focusing on the 
importance of genetic testing for ever one presumed to be at high risk evidenced high 
mean scores and low variances. This 'mding concurs with what has been reported in the 
literature on how families influence members' awareness of cancer risk and decisions 
about becoming involved in genetic testing (Bleiker et al., 2003; Gaff et al., 2005; Koehly 
et al. , 2003; Peterson et al., 2003). I 
Two of the subscales address preparation for and involvement in the process (GTP) 
and wait-time concerns (WC). The mo~erate to high scores in the GTP subscale suggest 
that respondents value being adequatel emotionally prepared for genetic testing and 
having the appropriate information. Al \hough only a few research studies address this, 
several authors suggest greater researc efforts are needed to inform genetic counselors 
about the needs and concerns of individuals and families seeking genetic testing (Bleiker 
et al., 2003; Pieterse et al., 2005). The ther important finding of the current study is that 
not everyone needs support from a genetic counselor throughout the process. This finding 
concurs with the conclusions derive(! from a review of the literature by Bleiker et al. 
These authors emphasize the need f0r further research to determine the professional 
support needs of individuals and £ \ ilies. 
The moderate scores in the WC subscale indicate that study respondents 
I 
experienced some level of emotiona difficulty while waiting for genetic testing results. 
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This finding is comparable to Meise 's (2005) conclusions following an extensive review 
of relevant literature. However, as eiser noted, the limited information on the extent of 
psychological distress experienced by individuals at this time is an important gap in our 
understanding. 
Additional subscales are desig ed to capture the support needs of individuals during 
and following receipt of genetic testi 'g results (SGTR) and their understanding of 
personal risks (UR). The moderate sc re range for the SGTR suggests that not everyone 
has high support needs prior to and dUring the receipt of results. Nevertheless, most 
respondents placed high value on receiving a follow-up letter detailing their genetic 
testing results. These findings reinfor e the assertions made by other researchers that 
genetic counseling sessions should be individualized and consider family dynamics 
(Bleiker et al., 2003; Pieterse et al. , 2005). 
The relatively high UR subscale 1 cores in the current study indicate that most 
respondents understood the importanc1 attached to being proactive in attitude and action 
towards healthy living and screening behaviors. According to McAllister (2002), 
previous quantitative studies have failek to consistently predict outcomes from genetic 
testing. In fact, most of the literature has focused on the psychological impact of genetic 
testing, as opposed to its impact on subsequent behavior. Most importantly, it cannot be 
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assumed that individuals will adopt appropriate screening behaviors as they become 
aware of their risk status (Meiser, 2005). So while respondents may understand their risk 
and intend to participate in recomm nded screening, previous study findings suggest that 
screening intentions do not always t anslate into actual behavior (Bleiker et al. , 2005). In 
fact, Bleiker et al. found that while noncompliance was rare, there were instances of 
significant delays in the screening p actices. 
Another subscale is designed to capture family members ' awareness of and beliefs 
about cancer transmission (TB) withm families. The moderately high score range for this 
subscale could be a function of actua variations in cancer patterns or awareness levels. 
One exception to this general statemr t is that most respondents perceived increases in 
cancer among young people. This pe ception is supported by actual statistics from local, 
national and international contexts (L nch & de la Chapelle, 2003; Lynch et al. , 2008; 
Merg et al., 2005; Stuckless et al. , 2007). 
The remaining subscales are developed to measure the importance attached to and 
the perceived receptivity of individua s to information about HNPCC family risk (COL) 
and issues confronting them while disclosing this information to others (DI). The 
moderately high scores for the COL suggest that most family members, young and old 
alike, wanted information about HNPC!:C and were perceived to understand it. While the 
research is fairly extensive in terms of ow information is communicated to family 
members, there are limited research findings reported in the literature on how well this 
information is received and understoo (Gaff et al., 2005; Peterson et al. , 2003). 
In contrast, the moderately high scores for the DI suggest that respondents may 
have encountered some difficulties in communicating this information to other family 
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members. This finding is comparab e to what others have reported about disclosure 
difficulties (Carlsson & Nilbert, 2007; Esplen et al., 2007). Communication issues can 
have significant implications for ho other family members understand their risk, 
whether or not they seek genetic counseling and testing and if they engage in screening 
(Gaff et al., 2005; Koehly et al., 2003; Peterson et al., 2003). Several authors also suggest 
that certain individuals could benefi from ongoing contact with geneticists to receive up-
to-date information about HNPCC and its management, as well as, for support in the 
disclosure of information to other f:l ily members (Collins et al., 2007; Gaff et al. , 2005; 
Koehly et al., 2003; Mesters et al., 2 05, Peterson et al., 2003). 
Summary 
Preliminary findings from this pilot study indicate that the HD-GT is a 
psychometrically sound scale. The usf of qualitative data to construct the HD-GT has 
resulted in an instrument that is steep d in the experiences of individuals living in 
families with HNPCC. This instrument has been developed based on the substantive 
theory Confronting and Accepting the Challenges of Living in Families with Genetic-
Linked Diseases and the content and r~sults provide support for other findings reported in 
the literature. In conclusion, the preliminary findings also indicate that the subscales are 
appropriate for use under variant cond.tions and appear to be sensitive enough to measure 
the wide-range of psychosocial and belrravioral implications of genetic testing. 
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CHAPTER6 
Limitations and Implications 
This chapter presents a discussion on the limitations and implications of the pilot 
study findings. The first section sur arizes the limitations and strengths of the study. 
The second section presents an ove view of the implications for nursing practice, 
education, leadership/administratio , and research. 
Limltations and Strengths 
The small sample size in this study limits the generalizability of the findings, and 
results should be interpreted with caution. Despite the good response rate (63%), the 
study is based on the responses of o ly 45 carriers and 30 non-carriers. It is hoped that 
the ongoing larger study with a grea er sample size will validate the findings of this pilot 
study. In addition, there may besom response bias as the sample population has 
previously been involved in other stj dies relating to HNPCC and some respondents may 
have given answers that they though were expected. 
One ofthe strengths ofthis s ~dy has been the development of a monitoring scale 
that is easily understood and can be dministered with or without support of a 
professional. This will allow the seal to be utilized more broadly in practice. A second 
strength is that it was developed from qualitative data derived from a study conducted 
locally and, therefore, the content would be expected to be quite relevant to the HNPCC 
population in this province. 
Implications 
Study findings have important implications for nursing practice, education, 
leadership/administration, and rese ch. The following discussion presents the 
implications for each of these com11onents in a separate section. 
Nursing Practice 
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It is widely documented in t e literature that the family physician and other 
primary care practitioners must be cognizant of the features of HNPCC, be aware of the 
extracolonic cancers associated wit HNPCC, and be able to do an extensive family 
history on the patient. These clinicians play an important role in the identification of 
high-risk individuals and provide fi llow-up care after a diagnosis has been made. Health 
care providers (HCPs) are also ani portant link in encouraging individuals to engage in 
the recommended screening (Lindor et al. , 2006; Lynch et al. , 2008; Merg et al. , 2005). 
With the current shortage of nearly ll HCPs, it is extremely important that nurses and 
nurse practitioners (NPs ), working o their full scope of practice, assume some of these 
roles. 
Nurses and NPs are in a uni ue position to identifY patients who would benefit 
from genetic counseling and/or genetic testing. This may occur in the context of other 
services being provided such as in cervical screening clinics and wellness clinics. Nurses 
and NPs may have responsibility fo collecting patient and family history information. 
According to Kurnat-Thoma (2008) a complete and thorough family history is the best 
screening mechanism for identif)rin potentially at-risk family members. This researcher 
proposes that the nurse ' s role in taki g family histories, making referrals for genetic 
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testing, and supporting patients while they undergo screening is crucial. Since nurses and 
NPs work in all settings- acute ewe, long term care, community, education, and in 
I 
private industry, they are in the un'que situation of being the one HCP who typically 
spends the most time with a patien . This gives them the opportunity to get to know 
patients better than other HCPs and gather information from and provide relevant 
information to patients. Nurses in ll settings should assess the structure of families, as 
well as their communication patte+ s and how these factors may influence decisions 
about genetic testing. 
The Amsterdam I, Amsterd II and Bethesda guidelines (Appendix A) can assist 
nurses in assessing which patients are appropriate candidates for genetic counseling. 
Given the importance of clinical ju · gment, especially in cases where there is suspicion of 
HNPCC but genetic testing has been inconclusive, nurses must know the cardinal signs of 
HNPCC and also be able to identi potential patients based on pattern recognition and 
family history as recommended by erg et al. (2005). This can be especially important in 
small families or in cases where there is reduced penetrance. 
The screening adherence ra es among these high-risk, HNPCC families tend to be 
below recommended levels and thee are often a number of individuals at risk in the 
family (Linder et al., 2006). Nurses and NPs must be made aware of appropriate and 
evidence-based screening guidelines and recommendations. These recommendations are 
vitally important for individuals who are mutation positive or for whom the genetic 
testing is inconclusive. Nurses and Ps can also provide assistance by facilitating 
communication among family me bers as well as educating individuals and families 
about screening. 
In addition to educating clients and making the necessary referrals, nurses and 
NPs can help in assessing and mee ing physical, psychological and social needs of 
individuals in these families. They are also equipped to be coordinators of care for the 
patient, who sometimes finds it dif 1cult to navigate the health care system. 
Many authors promote a multidisciplinary approach to genetic services for 
patients with HNPCC (Claes et al. 2005; Collins et al. , 2007; Kurnat-Thoma, 2008; 
Meiser, 2005). Nurses have an important role to play in this essential multidisciplinary 
collaboration. The nurse's role ca~ include obtaining thorough family histories, 
promotion of recommended screening and health maintenance practices, supporting 
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individuals undergoing screening, as well as making referrals for genetic counseling and 
testing (Kurnat-Thoma). 
Unfortunately to date, Canadian nursing organizations have not identified genetics 
to be within the scope of professional nursing practice. It appears that nurses in the 
United States have taken more of A leadership role in developing roles for nurses in the 
field of genetics; however nurses in Canada do deliver genetic services (Bottorff et al., 
I 
2005). Some of the roles currently held by Canadian nurses in this field include genetic 
counseling, community genetics, genetics education, clinic coordination and genetics 
research (Bottorff et al.). This is clearly an area where further development is needed to 
I 
define the required competencies for nurses to provide this type of service. 
Nursing Education 
The results of this study h lve important implications for basic nursing education 
and continuing education for nurses and NPs. Nurse educators must be aware of the role 
89 
for nurses in identifying patients wpo could benefit from genetic counseling as well as in 
recommending evidence-based cancer surveillance and be prepared to teach these 
competencies and skills. In additior , nurse educators must teach their students the skills 
for assessing and helping meet patients' psychological needs, assessing family structure, 
as well as strategies for facilitating individual and family discussions and decision-
making around genetic counseling b d testing. In addition, students need to be aware that 
coordination of care is an integral qart of the nurses' role and that it has direct 
implications for the well-being of the patient. Furthermore, the role of the nurse on 
multidisciplinary teams should be a component of basic nursing education. 
Continuing education for ntlrses and NPs should include education on HNPCC 
and its cardinal features, such as in~omplete penetrance, extracolonic cancers, early age 
of onset, etc., so that nurses can assist in identifying potential patients and families who 
could benefit from genetic counsel" ng and testing. NPs, in their role as primary care 
practitioners, must be aware of the · mportance of taking an extensive and appropriate 
family history so that the potential resence of HNPCC can be detected. Continuing 
education programs should provid evidence-based recommendations for cancer 
surveillance as well, so that nurses and NPs can encourage and support their patients to 
engage in recommended screening rotocols. As well, education should include 
information about the psychosocial and behavioral implications that arise from being part 
of a HNPCC family . 
In addition, as noted in apr vious section, once competencies have been defined 
for nurses in genetics, they must be taught in nursing education at both the basic and the 
continuing education levels. There ~ay also be a role for graduate programs in which 
there is an opportunity for nurses to have designation as a clinical nurse specialist in 
genetics. Finally, certification prog~ams may need to be developed in this specialized 
area. 
Nursing Leadership and Adminis ration 
90 
Nursing administrators are constantly being challenged to find alternate methods 
of service delivery and to operate I ithin government- allocated budgets. Having all 
nurses work to their full scope of p actice is one method that is currently on the forefront 
as a strategy to help manage the shortage of all HCPs in the system. It has been identified 
in the preceding section that there is a role for nurses to play in caring for and/or 
coordinating the care of patients and families with HNPCC. Nurse administrators would 
be wise to pursue these models in e current health care environment. 
Given the need for competJncies to be developed to incorporate genetics into the 
scope of professional nursing prac ice, nursing leaders and administrators in all nursing 
organizations must promote this r Jquirement and engage in appropriate policy 
development to ensure this option aterializes. A strategic approach will be needed at all 
levels of nursing leadership and a ministration in order to bring this need into existence. 
Nursing Research 
This study utilized the findings from a qualitative study to design an instrument to 
measure the psychosocial and behkvioral impact of genetic testing for HNPCC. This pilot 
study is part of a larger study wit longitudinal components which is ongoing and is using 
a descriptive correlational design o develop, validate and evaluate monitoring tools. It is 
anticipated that the longitudinal component of the larger study will further validate the 
HD-GT and allow generalizability of~e preliminary findings of this pilot study. 
Research is ongoing in a larger study to further test the substantive theory, 
Confronting and Accepting the Challenges of Living in Families with Genetic-Linked 
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Diseases (Way et al. , 2008). Only the rst two constructs of this theory have been utilized 
in the development of the HD-GT scale. Another scale is also being developed and tested 
from the data pertaining to the third construct, struggling to adjust. This scale will 
I 
measure how the individuals and families adjust to their mutation status and potential 
diagnosis, including adhering to recom ended screening protocols. The combination of 
these two scales will measure the complete psychosocial and behavioral adjustment of 
living with HNPCC. It is hoped that the larger study will also demonstrate that these tools 
can be generalized for use with individuals and families with other genetic-based 
diseases. 
While there have been significant hdvances in DNA technology in the past number 
of years, there is still a group of patients for whom this technology has not been 
successful. As indicated in Chapter 1 of this thesis, only approximately one half of 
HNPCC families will have a MMR mutation identified. It is presumed that there are 
alterations not yet detected or genes involved that have not yet been discovered. In 
addition, some individuals and families who have been presumed to be negative may 
have hidden alterations in known predisposition genes. This indicates a need for further 
research in the field of genetics. In additibn, there are implications for nursing research 
into the psychological implications ofthi inconclusive finding. 
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Conclusion 
This pilot study tested the psych metric properties of the HD-GT scale. This scale 
was developed from data from a previous qualitative study and is meant to measure the 
psychosocial, behavioral and emotional impact of genetic testing for HNPCC. 
Preliminary findings from this component of the project were able to confirm that 
this scale was appropriate to use under variant conditions (face-to-face, telephone and 
self-administered). In addition, subscale and overall scale structure were validated and the 
scale met Likert scaling assumptions. 
Although these findings cannot be generalized at present, it represents work that has 
not previously been done with this popJJation and offers the opportunity for further 
research. The larger study that is ongoing will allow for this research and for further 
refinement of the scale. 
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Amsterdam I criteria 
At least three relatives have histologi ally verified colorectal cancer (CRC) and all of the 
following criteria are met: 
~ One individual is a first-degree relative of the other two; 
~ Disease is present in at least two successive generations; 
~ At least one ofthe relatives w th CRC is diagnosed at <50 years of age; 
~ Familial adenomatous polyposis (F AP) has been eliminated as a possibility. 
Amsterdam II criteria 
At least three relatives have some for of hereditary nonpolyposis colorectal cancer 
(HNPCC)- colorectal cancer, endometrial, stomach, ovary, ureter/renal pelvis, brain, 
small bowel, hepatobiliary tract, and skin (sebaceous tumors): 
~ One is a first-degree relative o the other two; 
~ At least two successive generations affected; 
~ At least one of the HNPCC cl cers should be diagnosed at <50 years of age; 
~ F AP is excluded as a possibili y in any CRC cases; 
~ Tumors are verified whenever possible. 
Bethesda Guidelines for testing of colo rectal tumors for microsatellite instability 
~ Individuals with cancer in families that meet the Amsterdam Criteria; 
~ Individuals with two HNPCC-related cancers, including synchronous and 
metachronous colorectal cancers (CRC) or associated extracolonic cancers; a 
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);- Individuals with CRC who have a first-degree relative with CRC and/or HNPCC-
related extracolonic cancer i d/or a colorectal adenoma. One of these cancers is 
diagnosed less than 45 years f age, and the adenoma is diagnosed less than 40 
years of age; 
);- Individuals diagnosed with CRC or endometrial cancer less than 45 years of age; 
);- Individuals with right-sided CRC that evidences an undifferentiated pattern (solid/ 
cribiform) on histopathologyr d are diagnosed less than 40 years of age; b 
);- Individuals with signet-ring- ell-type CRC diagnosed less than 45 years of age; c 
);- Individuals with adenomas diagnosed less than 40 years of age. 
a Endometrial, ovarian, gastric, hepa obiliary, or small-bowel cancer or transitional cell 
carcinoma of the renal pelvis or uret~r. 
b Solid/cribiform is defined as poorl differentiated or undifferentiated carcinoma 
composed of irregular, solid sheets of large eosinophilic cells and containing small gland-
like spaces. 
c Composed of more than 50% of s~gnet ring cells. 
Note: Derived from Merg, Lynch, Lynch and Howe (2005) 
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School of Nursing 
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Dear Dr. Way: 
St. Clare·s Mercy Hosp/lal 
Sl. John's. NL 
Canada A1C 588 
T · (709) 777-5233 
F: (709) 777-5272 
www.easlemheallh.ca 
Your research proposal "HIC # 08.018 - Psychometdc testing of scales designed to monitor the 
psychosocial and behavioral impact of genetic testing for Hereditary Non polyposis Colorectal 
Cancer (HNPCC) " was reviewed by the Research Proposals Approval Committee (RPAC) of 
Eastern Health at its meeting on March 7 2008 and we are pleased to inform you that the 
proposal has been approved. 
The approval of this project is subject to the following conditions: 
• The project is conducted as outlined in the HIC approved protocol; 
• Adequate funding is secured to support the project; 
• In the case of Health Records, e~orts will be made to accommodate requests based 
upon available resources. If you equire access to records that cannot be 
accommodated, then additional fees may be levied to cover the cost; 
• A progress report being provided upon request. 
If you have any questions or comments, please contact Donna Bruce, Manager of the Patient 
Research Centre at 777-7283. SMJL \ 
I 
Mr. Wayne Miller 
Senior Director Corporate Strategy & Research 
Chair, RPAC 
Eastern Health 
cc: Ms. Donna Bruce, Manager Patient Research Centre 
Dr. Sandra LeFort, Director of MUN School of Nursing 
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Tell phone Survey Script 
Study Number: _______ _,_I 
Location of Residence: I 
Hello. Is this 709 L_--~~-_-)-?-=---1 -
If response is yes: May I speak to - -=--\ ____ _ 
(name)? \ 
My name is and I am alling from the Patient Research Centre in St. 
John's with respect to a province wide survey ofHNPCC families. The Centre has 
initiated a number of studies with individuals who have been tested for the HNPCC gene. 
You may have already participated in lone or more of these studies. 
We are now trying to contact interested people who may be willing to help us build upon 
previous work. I would really appreci te some of your time this 
morning/afternoon/evening. 
The Patient Research Centre is trying to determine individuals/families experiences 
with genetic testing and identify any identify any issues with screening, accessing 
needed resources and interacting wi h the health care system. Approximately 400 
individuals are being contacted to a~swer a brieftelephone survey. Your 
participation is very important to us. The questions will take about 45 to 60 minutes 
to complete. Of course, you may refu e to answer any questions. Your comments 
will be held in strictest confidence an (I no names will be used. Your participation 
will help us better understand the le el of satisfaction with genetic testing and health 
care provided, as well as system changes that may be needed. 
Would you mind being sent materials for you to look at more closely to help you 
decide about participating in the stud~? 
I 
\ 
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Call Back Statements 
If respondent is reluctant or hesitates read the following: 
If you would like to speak to someo e about this survey, you are welcome to call collect 
to our supervisor at 709-777-6872. 
\ Closure 
Well, that's all for now. I really appr~ciate your cooperation. Thank you very much for 
your time. 
Response to "How did you get my telephone number" 
If respondent is annoyed that you ran~ them, they may ask how you obtained their 
number. Respond with the following: 
When you were involved in genetic te~ting for HNPCC, you provided the 
geneticist/genetic counselor with contact information (your name, telephone number and 
address). 
If further assistance is needed 
Approximately 400 individuals from different families with HNPCC will be contacted in 
this survey and your comments will be peld in strictest confidence and no names will be 
used. 
If necessary give them the call back sta ement at the top of this page. 
11 1 
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1 March 2008 
Dear 
Thank you for agreeing to review th materials for our research study about HNPCC as 
discussed on the telephone. We are asking people to participate in an interview that may 
last about 45 to 60 minutes. A second interview might be requested in the future. These 
sessions will focus on your experiences with genetic testing, your reasons for choosing 
genetic testing and the short- and long-term impact oftest results on you and your family. 
Once we receive your written agree ent to participate in the study, a follow-up phone 
call will be made by a member of our research team to schedule an acceptable time to 
complete the questionnaire. 
Enclosed you will find a study information sheet, a copy of the survey questionnaires and 
two consent forms for you to review. If you require more information about the study and 
your participation, please contact Chr"stine Way at 777- 6872. 
We appreciate your help. We hope that the answers you provide will improve the care of 
individuals who have cancer in their fan1ilies. 
Yours sincerely, 
Christine Way, PhD 
Principal Investigator 
NL Colorectal Cancer Study 
Brief Overview of Research Stud)[ 
Title: Psychometric Testing of Sea es Designed to Monitor the Psychosocial and 
Behavioral Impact of Genetic Testi g for Hereditary Non polyposis Colorectal Cancer 
(HNPCC) 
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Investigators: Dr. Christine Way, Dr. Mary Jane Esplen, Dr. Deborah Gregory, 
Dr. Patrick Parfrey, Kathy Watkins, Valerie Ludlow and Holly 
LeDrew 
Objectives of the study: 
1. 
2. 
3. 
To explore the usefulness of researcher-developed scales for assessing individuals 
experiences with genetic testing and short- and long-term adjustment in the 
I 
aftermath. I 
To develop a greater underst~ding of the impact of genetic testing for HNPCC 
on carriers and non-carriers, .~d their families. 
To identify relevant informati n that will facilitate the provision of health care 
services to more adequately address the needs of individuals belonging to families 
with documented hereditary c~lorectal cancer. 
Rationale for the study: 
Limited research has been conducted on the impact of genetic testing for individuals at 
risk for hereditary colorectal and related-cancers. Genetic testing provides an opportunity 
to help predict an individual's risk of developing these cancers. With the ability to predict 
or anticipate health threats, there may also be increased fear, worry or distress. Also, we 
know little about how such testing may\ influence screening and health practices. The 
research has tried to address these gaps by developing two scales from interview data 
with family members. 
Brief description of the study: 
The proposed study will attempt to assess individuals' experiences with genetic testing 
for HNPCC and adjustment to a carrier 0r non-carrier status. Individuals will be asked to 
participate in one to two interviews which are expected to last approximately 45 to 60 
minutes. Interviews will focus on your e~periences with genetic testing, your reasons for 
choosing genetic testing and the short- ab.d long-term impact oftest results on you and 
your family. 
Procedure for obtaining consent: 
A written, informed and witnessed conse t will be obtained prior to the first scheduled 
interview. 
Proposed staring date: 03/01/08 
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Faculty of Medicine, Schools of Nursing and Pharmacy of Memorial 
University of Newfoundland; Ea tern Health; Dr. H. Bliss Murphy Cancer Centre 
Consent to Take Part in Health Research 
TITLE: Psychometric Testing of Scales Designed to Monitor the Psychosocial 
and Behavioral Impact of Genetic esting for Hereditary Non polyposis Colorectal 
Cancer (HNPCC) 
INVESTIGATOR(S): Dr. Ch,ristine Way (709-777-6872), Dr. Mary Jane 
Esplen (416-340-4736), Dr. Debora~ Gregory (709-729-6977), Dr. Patrick Parfrey 
(709-777-7261), Kathy Watkins (70p-777-8142), Valerie Ludlow (709-781-0263), and 
Holly LeDrew (709-834-6121) (Co-investigators) 
SPONSOR: I 
You have been invited to take part in a research study. It is up to you to decide whether 
to be in the study or not. Before you decide, you need to understand what the study is 
' for, what risks you might take and what benefits you might receive. This consent form 
explains the study. 
A member of the research team will: 
• discuss the study ~ith you \ 
• answer your questions 
• keep confidential any information which could identify you, and 
• be available during the study o deal with problems and answer questions 
If you decide not to take part in or to leave the study, this will not affect your normal 
treatment. 
1. Introduction/Background: 
This study is a continuation of a large~;" project that has been looking at the impact 
of hereditary cancer on people. Two of the scales that will be used were developed 
from information obtained from peop e who know their HNPCC status and are now 
living with this knowledge. It is hoped that the information obtained from this study 
will guide health care providers in givi g better care to individuals and families and 
hopefully improve their quality of life. 
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2. Purpose of study: 
This study is looking at the short- and long-term effects on individuals and families 
living with hereditary cancer, being tested for the HNPCC gene, and finding out 
their HNPCC status. \ 
3. Description of the study procedures and tests: 
This study will look at people's ex~eriences with genetic testing for HNPCC and 
their adjustment to knowing their carrier status. You will be asked to participate in 
one to two interviews. The first int rview might be face-to-face or by phone based 
upon what you would like and where you live in the province. Also, if you are 
willing, you may be asked to fill out the questionnaire again in the future. A copy of 
the questionnaires is included in your package of material. 
4. Length of time: 
Each phone call or face-to-face inter iew will take about 45 to 60 minutes. 
5. Possible risks: 
It is possible that during the interview you may think about difficulties to do with 
genetic testing and the time since then. This may cause you to have some upsetting 
thoughts and feelings. 
You may refuse to answer any questions and end the phone call and your part in 
this study at any time. The interview~r may also end the phone call at any time and 
refer you to your genetic counsellor i he/she feels it would be helpful to you. 
6. Benefits: 
It is not known whether this study will benefit you. 
7. Liability statement: I 
Signing this form gives us your consent to be in this study. It tells us that you 
understand the information about the\research study. When you sign this form, you 
do not give up your legal rights. Researchers or agencies involved in this research 
study still have their legal and profess~onal responsibilities. 
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8. Confidentiality: 
Any information that you provide will be kept strictly confidential, safe in a locked 
file, and available only to the research team. Also, your name will not appear in any 
report or article as a result of this study. 
9. Questions: 
If you have any questions about taking part in this study, you can meet with the 
investigator who is in charge of the study at this institution. That person is: 
Dr. Chris ine Way (709-777-6872) 
Or you can talk to someone who is not involved with the study at all, but can advise 
you on your rights as a participant in a research study. This person can be reached 
through: 
Office of the Human Investigation Committee (HIC) at 709-777-6974 
Em il: hic@mun.ca 
I 
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Signature Page 
Study title: Psychometric Testing of Scales Designed to Monitor the Psychosocial 
and Behavioral Impact of Geneti Testing for Hereditary Non polyposis Colo rectal 
Cancer (HNPCC) 
Name of principal investigator: r. Christine Way 
To be filled out and signed by the participant: 
Please check as appropriate: 
I have read the consent and information sheet. 
I have had the opportunity to ask questions/to discuss this study. 
I have received satisfactory answers to all of my questions. 
I have received enough information about the study. 
I understand that I am free to withdra from the study 
• at any time 
• without having to give a reaso 
• without affecting my future c re 
I understand that it is my choice to be in the study 
and that I may not benefit. 
I agree to take part in this study. 
Signature of participant 
Signature of witness 
Important for Files! 
To be signed by the investigator: 
Date 
Date 
Yes { } No { } 
Yes { } No { } 
Yes { } No { } 
Yes { } No { } 
Yes { } No {} 
Yes {} No { } 
Yes { } No {} 
I have explained this study to the best of my ability. I invited questions and gave answers. 
I believe that the participant fully unde stands what is involved in being in the study, any 
potential risks of the study and that he or she has freely chosen to be in the study. 
Signature of investigator Date 
Telephone number: 
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APPENDIXE 
Survey Instruments 
Demographic Profile 
Study Number: _____ _ 
Today's Date: __________ _,_ __ 
We are interested in some information about your past medical history. Please use an X 
or write your answer in the space provided. 
Gender: Male Female 
Current Age in Years: ___ _ 
Yes No Have you ever been screened for cancer? 
If Yes, please indicate what type of eening and how often: 
(e.g., colonoscopy, every 2 years) 
Type of screenin2 
I 
I 
I 
I 
I 
I 
I 
Have you ever been told you have cancer? _ Yes _No 
If Yes, please indicate what type: 
Bowel Cancer 
_ Reproductive in women: 
Endometrial 
Ovarian 
Stomach 
Pancreas 
_ Kidney 
How often 
Other: 
------+- -------
Other: 
------+- -------
Have there been any changes in your health since the last questionnaire? 
Have there been any changes in the health o close family members since the last 
questionnaire? ___________ -:-- --------------
Thank you for filling out this questionnaire. © Way, Watkins & Ludlow 
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HNPCC Survey Questionnaire A 
(Familial Cancer and Genetic Testing Scale) 
This survey questionnaire has 10 questions. 
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Each question has several statements that we would like you to rate from 0 
(Not at all) to 4 (Extremely). 
Please circle the best answer for each. 
Thank you. 
121 
Al. We want to know the deg}ee to which a family history of cancer 
influences a person's decision to have genetic testing for HNPCC. 
Using the scale given, you are asked to rate how important each 
statement was in helping you to decide to have genetic testing done. 
0- Not at all 
1 - A little bit 
2 - Moderately 
3 - Quite a bit 
1. It seemed like a lot of family members were 
getting cancer more often an.d at a younger age 
0 1 2 3 4 than in past generations. 
2. I have many memories of close family members 
suffering from cancer illness and treatment 
0 1 2 3 4 
effects. 
3. The presence of so much carer in the family 
was hard to accept, and I wa ted to know why. 0 1 2 3 4 
4. It was scary to see the same pattern of cancer 
showing up in every generation of my family. 0 1 2 3 4 
5. It was so draining to lose clo e relatives to 
cancer that it got to a point when the phone rang 
0 1 2 3 4 I wondered who was sick this time. I 6. With so much suffering and early deaths from I 
cancer, I was worried about y own health and 
0 1 2 3 4 I death. 
7. What worried me was that even when a family 
member seemed to beat the odds with one form 
of cancer, another one show~d up. 0 1 2 3 4 
8. The stress of so much cancer in the family, more 
so in younger members, pulled some of us 
0 1 2 3 4 closer together but pushed otpers apart. 
9. I grew tired of how certain fa~ily members 
tried to hide the cancer from he children. 0 1 2 3 4 
I 
--
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I 
A2. We want to know to what extent you were thinking about a 
genetic link to cancer in your family prior to having contact with a 
geneticist/genetic counsellor, and how you reacted to being told that 
you were potentially at risk. I 
Using the scale given, you are asked to rate how important each 
statement was in helping you to prepare for genetic testing. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. Over the years concerns were expressed by some 
family members that there was a cancer gene in 
0 1 2 3 4 our family. 
2. It was only after the geneticist made contact with 
family members that I really began to think that 
the cancer had to be a family thing and I could 
0 1 2 3 4 also be at risk. 
3. When I knew that there was a study looking to see 
if my family had the cancer ~ene, I was relieved. 0 1 2 3 4 
4. When I was told that there w'rs a test that could 
find the cancer gene in the family, it was not a 
matter of "would I go for genetic testing", but 
"when I could have it". I 0 1 2 3 4 
5. I really questioned whether !(no wing if I am a 
carrier for HNPCC would do me more harm than 
good (i.e., restricted insuran e coverage and job 
0 1 2 3 4 prospects). 
6. Doing the screening for cancer every couple of 
years became a constant reminder of just how at 
0 1 2 3 4 risk I was by being a part of~his family. 
I 
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7. poscopy test was Taking the prep for the colo 
such a pain that I did not want to be doing this 
unless it was needed. 0 1 2 3 4 
8. With so much cancer in the family I worried that 
something would show up o my next screening 
test. 0 1 2 3 4 
A3. Going through genetic testing may be different even for people 
within the same family. We want to know how informed you were 
and how emotionally prepared you were. 
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Using the scale given, you are asked to rate these statements in terms 
of their importance in helping you and others decide to take part in 
genetic testing. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
It is important to: 
1. Get enough information in a timely manner 
from geneticists/genetic col nsellors about 
HNPee. 0 1 2 3 4 
2. Receive enough informatiofo from 
geneticists/genetic counsel ors about the 0 1 2 3 4 genetic testing process. 
3. Feel no pressure to have genetic testing done. 0 1 2 3 4 4. Know ones HNPee status. 
5. Understand ones risk for Tee and accept 0 1 2 3 4 
the need for genetic testing 0 1 2 3 4 6. Know ones HNPee status o help 
children/grandchildren. 0 1 2 3 4 7. Have geneticists/genetic counsellors to 
support you during the genetic testing 
process. 0 1 2 3 4 8. Feel support and encouragement from family 
and/or friends. 0 1 2 3 4 I 
l 
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A4. Certain people within fam "lies refuse to participate in genetic 
testing for one reason or another. Concerns were expressed about the 
future well-being for them and their families. 
Using the scale given, you are asked to rate how well these statements 
describe your feelings about family members who refuse to have 
genetic testing. 
0- Not at all 
1 - A little bit 
2 - Moderate I y 
3 - Quite a bit 
4 - Extremely 
1. It is important for all family members at risk 
for HNPCC to take part in genetic testing. 
2. I am really concerned about family members 
who refuse to go for genetic testing. 
3. I feel that family members ho refuse to go 
for genetic testing do not understand their 
risks. 
4. I believe that family members who refuse 
genetic testing are fearful of knowing their 
results. 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
----- - ------------------------.--------------------------------------------
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AS. Different thoughts and eml tions were experienced by individuals 
within and across the study farpilies as they waited for their genetic 
testing results. 
Using the scale given, please rate how well these statements describe 
your feelings about the wait time between the giving of blood for 
genetic testing for HNPCC and the actual receipt of your results. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. It was a very trying time thinking about if I 
could be a carrier/non-earner for HNPCC. 
2. I was not really prepared f@r such a long 
time between having the tebt done and 
getting the results. 
3. I was unsure about how I 'Yould receive my 
results (e. g. , phone, letter, ·n person). 
4. I spent a lot of time thinking about how I 
would react to finding out tpY genetic 
testing results. 
5. I wondered if I would unde~stand what my 
genetic testing results reall meant for me. 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
..... 
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A6. People often report differe rit experiences about how they receive 
their results for HNPCC. 
Using the scale given, you are asked to rate the following statements 
in terms of their importance fo.- you. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
It is important to: 
1. Have a family member anc /or friend present. 0 1 2 3 4 
2. Get a phone call from geneticist/genetic 
counsellor prior to receivit your results. 0 1 2 3 4 
3. Have face to face contact ith a 
geneticist/genetic counsellG>r when receiving 
your results. I 0 1 2 3 4 
4. Receive a letter explaining the meaning of 
being a HNPCC carrier/non-carrier for 
yourself and others. 0 1 2 3 4 
I 
! 
A 7. People react differently to receiving their genetic testing results 
no matter how prepared they Jre. 
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Using the scale given, you are ~sked to rate these statements in terms 
of how well they reflect your situation after getting your results. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. When you know that your c~ ncer IS 
hereditary, you wonder and .vorry about 
when it will show up in the t ture. 
2. Despite feeling fully prepared when I went to 
find out my HNPCC status, I was surprised 
by the results. 
3. Knowing my HNPCC status brought a sense 
of closure to everything. 
4. The information received frop1 the 
geneticist/genetic counsellor about cancer 
risk was very clear and use~l. 
5. Follow-up contact with the gj neticist/genetic 
counsellor to discuss healthy lifestyles and 
screening schedules would have been 
helpful. 
6. Overall, it was better to kno~ if I was a 
carrier/non-carrier than not t know. 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
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AS. We want to know if being a carrier/non-carrier changed how you 
looked at healthy living and sc~eening behaviors. What is important 
is how understanding of ones r sk impacts choices about healthy 
living and screening behaviors. 
Using the scale given, you are asked to rate how well these statements 
apply to your situation. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. Encouragement and support from family and 
friends helps one accept the eed for healthy 
living and cancer screening. 
2. Regular screening will help detect cancer at an 
early stage. 
3. Appropriate screening for HNPCC is 
important for timely detection of colon and 
related cancers. 
4. Early detection of cancer wi 1 help improve 
treatment and disease mana~ement. 
5. Healthy living (exercise, dief) and a positive 
attitude will help increase well-being and 
decrease stress. I 
6. Taking responsibility for healthy liv ing and 
regular screening is importaljlt. 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
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A9. The presence of cancer in the family is often important in helping 
understand ones personal risk for HNPCC. 
Using the scale given, you are asked to show how well these 
statements reflect your family's situation. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. Family members are being d' agnosed with 
HNPCC cancers at a youngeJ age. 0 1 2 3 4 
2. Men and women seem to ha le different types 
of first cancers. 0 1 2 3 4 
3. Different types of cancer seem to be showing 
up today more than in past g . nerations. 0 1 2 3 4 
4. The number of family members with cancer 
b 'h tE . 0 1 2 3 4 seems to e greater w1t eac generatiOn. 
5. Physical appearance and per onality are good 
signs of who will inherit the CC gene. 0 1 2 3 4 
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AlO. The question 'who to tell and who not to tell about HNPCC in 
the family' is a concern for many people. The person who assumes the 
'messenger role' may face difficulties in telling others about HNPCC 
in the family. 
Using the scale given, you are asked to rate how well these statements 
apply to your situation. 
0- Not at all 
1 - A little bit 
2- Moderately 
3 - Quite a bit 
4 - Extremely 
1. It is important for young family members to be 
2. 
told about the presence of i-INYCC in the family. 
It is difficult having to tell younger family 
members about their possible isk for HNPCC. 
3. Younger family members see1 to be open to 
information about HNPCC in he family. 
4. Younger family members seery to understand 
what HNPCC in the family could mean for them. 
5. It is important for all family members to be told 
about HNPCC. I 
6. It is hard telling other family members about 
their possible risk for HNPCC 
7. Family members seem to be o en to information 
about HNPCC. 
8. Family members seem to unde stand what 
HNPCC could mean for them. 
9. It would be helpful if the mess ;!nger had 
guidance and support from geqeticists/genetic 
counsellors on how to tell othe s about HNPCC 
in the family. 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
0 1 2 3 4 
--~-
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10. It is important to protect the f ights of others 
when talking about who could be at risk for 
HNPCC in the family. I 0 1 2 3 
4 
© Way, Ludlow, Watkins & Gregory 




